<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment - McCleery, J - 2018 | Cochrane Library</title> <meta content="Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment - McCleery, J - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011905.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment - McCleery, J - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011905.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011905.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment" name="citation_title"/> <meta content="Jenny McCleery&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Oxford Health NHS Foundation Trust" name="citation_author_institution"/> <meta content="Rajesh P Abraham&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Surrey and Borders Partnership NHS Foundation Trust" name="citation_author_institution"/> <meta content="David A Denton" name="citation_author"/> <meta content="Sussex Partnership NHS Foundation Trust" name="citation_author_institution"/> <meta content="Anne WS Rutjes" name="citation_author"/> <meta content="Lee‐Yee Chong" name="citation_author"/> <meta content="UK Cochrane Centre" name="citation_author_institution"/> <meta content="Aalya S Al‐Assaf" name="citation_author"/> <meta content="Newcastle University" name="citation_author_institution"/> <meta content="Daniel J Griffith" name="citation_author"/> <meta content="Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust" name="citation_author_institution"/> <meta content="Shireen Rafeeq" name="citation_author"/> <meta content="Central Park Medical College" name="citation_author_institution"/> <meta content="Hakan Yaman" name="citation_author"/> <meta content="Faculty of Medicine, Akdeniz University" name="citation_author_institution"/> <meta content="Muzaffar A Malik" name="citation_author"/> <meta content="Brighton and Sussex Medical School, University of Brighton" name="citation_author_institution"/> <meta content="Marcello Di Nisio" name="citation_author"/> <meta content="University &quot;G. D'Annunzio&quot; of Chieti‐Pescara" name="citation_author_institution"/> <meta content="Gabriel Martínez" name="citation_author"/> <meta content="Robin WM Vernooij" name="citation_author"/> <meta content="Iberoamerican Cochrane Centre" name="citation_author_institution"/> <meta content="Naji Tabet" name="citation_author"/> <meta content="Brighton and Sussex Medical School" name="citation_author_institution"/> <meta content="n.tabet@bsms.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD011905.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/11/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011905.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011905.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011905.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Dietary Supplements; Ascorbic Acid [*administration &amp; dosage]; Cognition [physiology]; Cognition Disorders [*therapy]; Dementia [*prevention &amp; control]; Executive Function; Memory, Episodic; Mortality; Picolinic Acids [administration &amp; dosage]; Quality of Life; Randomized Controlled Trials as Topic; Trace Elements [*administration &amp; dosage]; Vitamin B Complex [*administration &amp; dosage]; Vitamins [*administration &amp; dosage]; alpha‐Tocopherol [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011905.pub2&amp;doi=10.1002/14651858.CD011905.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="sogqpCtr";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011905\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011905\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","ja","fr","de","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011905.pub2",title:"Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment",firstPublishedDate:"Nov 1, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Dementia and Cognitive Improvement Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011905.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011905.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011905.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011905.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011905.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011905.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011905.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011905.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011905.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011905.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>16951 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011905.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-sec-0148"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-sec-0041"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-sec-0042"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-sec-0070"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-sec-0142"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/appendices#CD011905-sec-0153"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/table_n/CD011905StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/table_n/CD011905StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author custom-tooltip" title="This author contributed equally to this work"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0002">Jenny McCleery</a><sup>a</sup></li> <li class="author custom-tooltip" title="This author contributed equally to this work"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0003">Rajesh P Abraham</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0004">David A Denton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0005">Anne WS Rutjes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0006">Lee‐Yee Chong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0007">Aalya S Al‐Assaf</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0008">Daniel J Griffith</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0009">Shireen Rafeeq</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0010">Hakan Yaman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0011">Muzaffar A Malik</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0012">Marcello Di Nisio</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0013">Gabriel Martínez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0014">Robin WM Vernooij</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information#CD011905-cr-0015"><i class="icon corresponding-author fa fa-envelope"></i>Naji Tabet</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information/en#CD011905-sec-0165">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 November 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011905.pub2">https://doi.org/10.1002/14651858.CD011905.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011905-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011905-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011905-abs-0011">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011905-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011905-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011905-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011905-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011905-abs-0001" lang="en"> <section id="CD011905-sec-0001"> <h3 class="title" id="CD011905-sec-0001">Background</h3> <p>Vitamins and minerals have many functions in the nervous system which are important for brain health. It has been suggested that various different vitamin and mineral supplements might be useful in maintaining cognitive function and delaying the onset of dementia. In this review, we sought to examine the evidence for this in people who already had mild cognitive impairment (MCI). </p> </section> <section id="CD011905-sec-0002"> <h3 class="title" id="CD011905-sec-0002">Objectives</h3> <p>To evaluate the effects of vitamin and mineral supplementation on cognitive function and the incidence of dementia in people with mild cognitive impairment. </p> </section> <section id="CD011905-sec-0003"> <h3 class="title" id="CD011905-sec-0003">Search methods</h3> <p>We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group’s (CDCIG) specialised register, as well as MEDLINE, Embase, PsycINFO, CENTRAL, CINAHL, LILACs, Web of Science Core Collection, ClinicalTrials.gov, and the WHO Portal/ICTRP, from inception to 25 January 2018. </p> </section> <section id="CD011905-sec-0004"> <h3 class="title" id="CD011905-sec-0004">Selection criteria</h3> <p>We included randomised or quasi‐randomised, placebo‐controlled trials which evaluated orally administered vitamin or mineral supplements in participants with a diagnosis of mild cognitive impairment and which assessed the incidence of dementia or cognitive outcomes, or both. We were interested in studies applicable to the general population of older people and therefore excluded studies in which participants had severe vitamin or mineral deficiencies. </p> </section> <section id="CD011905-sec-0005"> <h3 class="title" id="CD011905-sec-0005">Data collection and analysis</h3> <p>We sought data on our primary outcomes of dementia incidence and overall cognitive function and on secondary outcomes of episodic memory, executive function, speed of processing, quality of life, functional performance, clinical global impression, adverse events, and mortality. We conducted data collection and analysis according to standard Cochrane systematic review methods. We assessed the risk of bias of included studies using the Cochrane 'Risk of bias' assessment tool. We grouped vitamins and minerals according to their putative mechanism of action and, where we considered it to be clinically appropriate, we pooled data using random‐effects methods. We used GRADE methods to assess the overall quality of evidence for each comparison and outcome. </p> </section> <section id="CD011905-sec-0006"> <h3 class="title" id="CD011905-sec-0006">Main results</h3> <p>We included five trials with 879 participants which investigated B vitamin supplements. In four trials, the intervention was a combination of vitamins B6, B12, and folic acid; in one, it was folic acid only. Doses varied. We considered there to be some risks of performance and attrition bias and of selective outcome reporting among these trials. Our primary efficacy outcomes were the incidence of dementia and scores on measures of overall cognitive function. None of the trials reported the incidence of dementia and the evidence on overall cognitive function was of very low‐quality. There was probably little or no effect of B vitamins taken for six to 24 months on episodic memory, executive function, speed of processing, or quality of life. The evidence on our other secondary clinical outcomes, including harms, was very sparse or very low‐quality. There was evidence from one study that there may be a slower rate of brain atrophy over two years in participants taking B vitamins. The same study reported subgroup analyses based on the level of serum homocysteine (tHcy) at baseline and found evidence that B vitamins may improve episodic memory in those with tHcy above the median at baseline. </p> <p>We included one trial (n = 516) of vitamin E supplementation. Vitamin E was given as 1000 IU of alpha‐tocopherol twice daily. We considered this trial to be at risk of attrition and selective reporting bias. There was probably no effect of vitamin E on the probability of progression from MCI to Alzheimer's dementia over three years (HR 1.02; 95% CI 0.74 to 1.41; n = 516; 1 study, moderate‐quality evidence). There was also no evidence of an effect at intermediate time points. The available data did not allow us to conduct analyses, but the authors reported no significant effect of three years of supplementation with vitamin E on overall cognitive function, episodic memory, speed of processing, clinical global impression, functional performance, adverse events, or mortality (five deaths in each group). We considered this to be low‐quality evidence. </p> <p>We included one trial (n = 256) of combined vitamin E and vitamin C supplementation and one trial (n = 26) of supplementation with chromium picolinate. In both cases, there was a single eligible cognitive outcome, but we considered the evidence to be very low‐quality and so could not be sure of any effects. </p> </section> <section id="CD011905-sec-0007"> <h3 class="title" id="CD011905-sec-0007">Authors' conclusions</h3> <p>The evidence on vitamin and mineral supplements as treatments for MCI is very limited. Three years of treatment with high‐dose vitamin E probably does not reduce the risk of progression to dementia, but we have no data on this outcome for other supplements. Only B vitamins have been assessed in more than one RCT. There is no evidence for beneficial effects on cognition of supplementation with B vitamins for six to 24 months. Evidence from a single study of a reduced rate of brain atrophy in participants taking vitamin B and a beneficial effect of vitamin B on episodic memory in those with higher tHcy at baseline warrants attempted replication. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011905-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011905-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011905-abs-0012">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011905-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011905-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011905-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD011905-abs-0008">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011905-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011905-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011905-abs-0005" lang="en"> <h3>Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment </h3> <p><b>Review question</b> </p> <p>This review investigated whether people with mild cognitive impairment can reduce their risk of developing dementia, or can prevent their memory or other thinking skills from deteriorating further, by taking vitamin or mineral supplements. </p> <p><b>Background</b> </p> <p>Slight changes in memory and thinking skills are common as people get older. When these changes are worse than can be expected in normal ageing, but are not bad enough to make a person's usual activities difficult to manage, then the person is said to have mild cognitive impairment (MCI). People with MCI are at increased risk of developing dementia in the future. </p> <p>Vitamins and minerals are naturally occurring substances which are needed in the diet to maintain health. They have lots of different functions in the body and many are essential to keep the brain working properly. It has been suggested that supplementing a person's normal diet with extra doses of these vitamins or minerals might help to maintain thinking skills or prevent dementia. </p> <p><b>Study characteristics</b> </p> <p>We found eight randomised controlled trials (RCTs), which investigated four different types of vitamin or mineral pills by comparing them to a placebo (a dummy pill). The vitamins tested were B vitamins (vitamin B6, vitamin B12 and folic acid), vitamin E, and vitamin E and C given together. The only mineral tested was chromium. </p> <p><b>Key results and quality of the evidence</b> </p> <p><i>Vitamin B combination versus placebo</i> </p> <p>Five trials with a total of 879 participants compared B vitamins with placebo. Four used combinations of vitamin B6, vitamin B12, and folic acid; one small study tested folic acid on its own. None of these studies reported whether or not participants developed dementia. These studies did not find that memory or thinking skills differed between the group of people who took vitamin B supplements and those who took placebo after treatment lasting six months to two years. Our confidence in the results on different tests used in the studies varied from moderate to very low. Two years of vitamin B supplements did seem to help memory in a small subgroup of participants in one study who could be identified by a particular blood test at the start of the trial. One study found that there was probably no effect on participants' quality of life. One study scanned the brains of some participants and reported that B vitamins may slow the rate of brain shrinkage. </p> <p>Harmful effects and deaths were reported in very few participants and we cannot conclude whether or not there are harms from taking these or similar combinations of B vitamins. </p> <p><i>Vitamin E versus placebo.</i> </p> <p>One study with 516 participants compared a relatively high dose of vitamin E (2000 IU a day) to placebo in people who were also taking a multivitamin containing 15 IU of vitamin E (the daily requirement for vitamin E is approximately 30 IU). The risk of developing dementia due to Alzheimer’s disease (the commonest form of dementia) is probably not affected by three years of treatment with high‐dose vitamin E. The quality of the evidence for other outcomes was lower, but there may also be no effect of this dose of vitamin E on specific memory or thinking skills or on how well people could manage their daily activities. </p> <p><i>Vitamin E and C versus placebo</i> </p> <p>One study with 256 participants compared a combination of vitamins C and E with placebo. It found no effect on overall memory and thinking skills, but we had little confidence in this result because of the quality of the evidence. </p> <p><i>Chromium picolinate versus placebo</i> </p> <p>Only one very small study with 26 participants investigated the effect of chromium supplements. This study was too small for us to be able to draw any conclusions. </p> <p><b>Conclusions</b> </p> <p>The amount and quality of research evidence about vitamin and mineral supplements for treating MCI in people without nutritional deficiency is limited. At the moment, it is not possible to identify any supplements which can reduce the risk of people with MCI developing dementia or which can effectively treat their symptoms. More research is needed before we can answer our review question. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011905-sec-0148" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011905-sec-0148">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011905-sec-0221">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011905-sec-0148"></div> <h3 class="title" id="CD011905-sec-0149">Implications for practice</h3> <section id="CD011905-sec-0149"> <p>Currently, there is no evidence that any vitamin or mineral supplement is useful for preventing progression from MCI to dementia or for treating the symptoms of MCI. </p> </section> <h3 class="title" id="CD011905-sec-0150">Implications for research</h3> <section id="CD011905-sec-0150"> <p>Research on vitamin and mineral supplements for the treatment of mild cognitive impairment should be driven by strong hypotheses based on preclinical research. Studies should investigate mechanisms by measuring putative mediating factors. Ultimately, longer and larger studies will be needed to investigate outcomes which are important to patients, including improved functioning and quality of life, but at the current stage of research, shorter term studies with surrogate outcomes (biomarkers or cognitive test scores) remain suitable for hypothesis testing. Outcomes should be measured across several cognitive domains using instruments which are known to be sensitive to small changes in the presence of mild impairments. Trials should include evaluation of baseline nutritional status and assess how this interacts with treatment. Other possible moderating factors, based on the hypotheses being tested, should also be measured. </p> <p>Although there was no evidence of overall benefit from the studies included in this review, one study of B vitamins reported a slowing of brain atrophy in the whole study population and an attempt to replicate this result is needed. The same study reported that there may be a beneficial effect of B vitamins on episodic memory in the subgroup with higher homocysteine levels at baseline. However, the result of a very large individual patient meta‐analysis which found no effect of homocysteine‐lowering with B vitamins on cognitive ageing in 22,000 older participants without specific cognitive diagnoses at baseline makes this result less promising to pursue. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011905-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011905-sec-0029"></div> <div class="table" id="CD011905-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">B vitamins compared to placebo for MCI</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>B vitamins compared to placebo for MCI</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> MCI<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> B vitamins (B6, B12, folic acid)<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with B vitamins</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of dementia ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive function<br/> assessed with: MMSE<br/> Scale from: 0 to 30<br/> follow‐up: range 6 months to 24 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>MD with B vitamins was 0.44 MMSE points higher<br/> (0.23 lower to 1.12 higher) than with placebo * </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>488<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Due to the very low‐quality of the evidence, we cannot be sure of any effect of B vitamins on overall cognitive function. </p> <p>* 2 studies reported final score; 1 study reported change from baseline. From the 2 studies (n=150) which reported final scores, the mean MMSE with placebo was 26.97 points. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Episodic memory<br/> assessed with: various word list recall instruments<sup>a</sup><br/> follow‐up: range 6 months to 24 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>SMD with B vitamins was 0.09 higher<br/> (0.1 lower to 0.29 higher) than with placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>397<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>B vitamins probably resulted in little to no difference in episodic memory.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Executive function<br/> assessed with: various instruments<sup>b</sup><br/> follow‐up: range 6 months to 24 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>SMD with B vitamins was 0.03 higher<br/> (0.23 lower to 0.29 higher) than with placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>392<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>B vitamins probably resulted in little to no difference in executive function.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Speed of processing<br/> assessed with: various instruments<sup>c</sup><br/> follow‐up: range 6 months to 24 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>SMD with B vitamins was 0.04 higher<br/> (0.26 lower to 0.34 higher) than with placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>173<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>B vitamins probably resulted in little to no difference in speed of processing.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life<br/> assessed with: D‐QOL<br/> Scale from: 1 to 5<br/> follow‐up: 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life was 3.5 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0 points<br/> (0.1 lower to 0.1 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>138<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>B vitamins probably resulted in little to no difference in quality of life.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Reported by only one study (2/133 died in vitamin B group, 0/133 died in placebo group).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>MD:</b> Mean difference; <b>SMD:</b> Standardised mean difference; <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded due to risk of bias. One study was at high risk of performance bias and at unclear risk of selection and detection bias. </p> <p><sup>2</sup> Downgraded due to inconsistency. I<sup>2</sup> = 87%. </p> <p><sup>3</sup> Downgraded due to imprecision. 95% CI included little or no effect and small benefit of B vitamins. </p> <p><sup>4</sup> Downgraded due to imprecision. 95% CI included small effects in either direction. </p> <p><sup>5</sup> Downgraded due to imprecision. Result derived from one small study. </p> <p><sup>a</sup>Episodic memory assessed with Hopkins Verbal Learning Test, word learning and the Auditory Verbal Learning Test. </p> <p><sup>b</sup>Executive function assessed with CLOX, the Stroop test, and the Frontal Assessment Battery. </p> <p><sup>c</sup>Speed of processing assessed with Trail‐making Test A, digit cancellation, and the Digit‐Symbol Substitution Test. </p> <p><sup>CLOX: Clock drawing executive test<br/> D‐QOL: Dementia quality of life questionnaire</sup><br/> <sup>MCI: Mild cognitive impairment<br/> MMSE: Mini‐mental state examination</sup> </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011905-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vitamin E compared to placebo for MCI</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Vitamin E compared to placebo for MCI</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> MCI<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> vitamin E<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of dementia due to Alzheimer's disease<br/> follow‐up: 36 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>76 cases in vitamin E group and 73 cases in placebo group (HR 1.02, 95% CI 0.74 to 1.41) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>516<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning<br/> assessed with: MMSE and ADAS‐cog<br/> follow‐up: 36 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Single study reported no significant difference between groups in changes from baseline of MMSE or ADAS‐cog. Sample sizes not reported. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Episodic memory<br/> assessed with: z‐score incorporating various instruments<sup>a</sup><br/> follow‐up: 36 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Single study reported no significant difference between groups. Sample size not reported.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Executive functioning<br/> assessed with: z‐score incorporating various instruments<sup>b</sup><br/> follow‐up: 36 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Single study reported no significant difference between groups. Sample size not reported.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No significant difference in deaths reported between vitamin E, donepezil, and placebo groups during double‐blind phase of trial. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded due to imprecision. 95% CI around hazard ratio included possible effect in both directions. </p> <p><sup>2</sup> Downgraded due to imprecision. Single study. Sample size for this outcome not reported. </p> <p><sup>3</sup> Downgraded due to risk of bias. High risk of bias due to incomplete outcome data and selective reporting. </p> <p><sup>a</sup>Episodic memory assessed using standardised composite z‐score incorporating ADAS immediate and delayed word‐recall scores and the New York University immediate and delayed paragraph‐recall scores. </p> <p><sup>b</sup>Executive function assessed using standardised composite z‐score incorporating the digits‐backward test, Symbol Digit Modalities Test, and number‐cancellation test. </p> <p><sup>ADAS‐cog: Alzheimer's Disease Assessment Scale ‐ cognitive <br/> MCI: Mild cognitive impairment<br/> MMSE: Mini‐mental state examination</sup> </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011905-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Vitamin E + vitamin C compared to placebo for MCI</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Vitamin E + vitamin C compared to placebo for MCI</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> MCI<br/> <b>Setting: c</b> ommunity<br/> <b>Intervention:</b> vitamin E + vitamin C<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vitamin E + vitamin C</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of dementia ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive function<br/> assessed with: MMSE (Iranian version)<br/> Scale from: 0 to 30<br/> follow‐up: 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall cognitive function was 26.6 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.23 points higher<br/> (0.25 lower to 0.71 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Due to very low‐quality evidence, we cannot be sure of any effect of vitamin C + vitamin E on overall cognitive function. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Episodic memory ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Executive function ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Speed of processing ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded due to risk of bias. Unclear risks of selection, performance, and attrition bias. </p> <p><sup>2</sup> Downgraded due to indirectness. Inadequate definition of MCI. </p> <p><sup>3</sup> Downgraded due to imprecision. Result from a single small study. </p> <p><sup>MCI: Mild cognitive impairment<br/> MMSE: Mini‐mental state examination</sup> </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011905-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011905-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011905-sec-0175">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD011905-sec-0030"></div> <section id="CD011905-sec-0031"> <h3 class="title" id="CD011905-sec-0031">Description of the condition</h3> <section id="CD011905-sec-0032"> <h4 class="title">Mild cognitive impairment and dementia</h4> <p>Prior to the onset of dementia, there can be a prodromal (pre‐symptomatic) stage which is often termed 'mild cognitive impairment' (MCI). The category of MCI captures those individuals whose cognitive deficits are beyond those typically seen in normal ageing and who are at high risk of future dementia. Different criteria have been proposed to identify MCI, but, broadly speaking, MCI of the amnestic subtype is a state where individuals have subjective and objective memory impairment that is inconsistent with age, but normal global cognitive functioning, and normal performance in non‐memory cognitive domains. The main focus of these criteria is to detect memory problems due to prodromal Alzheimer’s disease (AD). However, not all forms of MCI evolve into AD dementia and, therefore, there have been calls for broader, more inclusive criteria. In 2003, an International Working Group (IWG) developed consensus criteria and expanded the definition of MCI to include objective and subjective impairments in any cognitive domain (<a href="./references#CD011905-bbs2-0167" title="WinbladB , PalmerK , KivipeltoM , JelicV , FratiglioniL , WahlundLO , et al. Mild cognitive impairment‐‐beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine2004;256(3):240‐6. ">Winblad 2004</a>). The influential Petersen criteria have been similarly extended (<a href="./references#CD011905-bbs2-0137" title="PetersenRC . Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine2004;256(3):183‐94. ">Petersen 2004</a>). In recent years, new criteria have been proposed for MCI due to AD, including the National Institute on Aging‐Alzheimer’s Association (NIA‐AA) criteria for preclinical/prodromal states (<a href="./references#CD011905-bbs2-0068" title="AlbertMS , DeKoskyST , DicksonD , DuboisB , FeldmanHH , FoxNC , et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's &amp; Dementia2011;7(3):270‐9. ">Albert 2011</a>), updated NIA‐AA research criteria (<a href="./references#CD011905-bbs2-0103" title="JackCR , BennettDA , BlennowK , CarrilloMC , DunnB , HaeberleinSB , et al. NIA‐AA research framework: toward a biological definition of Alzheimer's disease. Alzheimer's &amp; Dementia2018;14(4):535‐62. ">Jack 2018</a>), and updated versions of the IWG criteria (<a href="./references#CD011905-bbs2-0090" title="DuboisB , FeldmanHH , JacovaC , HampelH , MolinuevoJL , BlennowK , et al. Advancing research diagnostic criteria for Alzheimer'sdisease: the IWG‐2 criteria. Lancet Neurology2014;13(6):614‐29. ">Dubois 2014</a>). </p> <p>Dementia is a syndrome of cognitive and functional decline which is usually progressive and which involves impairment in more than one cognitive function, memory being the most commonly affected in the early stages. Other higher cortical functions such as orientation, comprehension, learning, language, and judgement are also often affected. In most cases, the onset of dementia and its subsequent progression is gradual. The cognitive deficits in the early stages of the illness are relatively mild, but still have an impact on the ability to perform some normal daily activities. As the syndrome progresses, people with dementia eventually become increasingly dependent on others for support with all activities of daily living. </p> </section> <section id="CD011905-sec-0033"> <h4 class="title">Types of MCI and dementia</h4> <p>There are numerous different definitions of MCI, with different focus (e.g. nature of the neuropsychological impairment, such as memory or non‐memory (<a href="./references#CD011905-bbs2-0117" title="MatthewsFE , StephanBC , BondJ , McKeithI , BrayneC . Operationalization of mild cognitive impairment: a graphical approach. PLoS medicine2007;4(10):1615‐9. ">Matthews 2007</a>); prevalence (<a href="./references#CD011905-bbs2-0155" title="StephanBC , MatthewsFE , McKeithIG , BondJ , BrayneC . Early cognitive change in the general population: how do different definitions work?. Journal of the American Geriatrics Society2007;55(10):1534‐40. [PUBMED: 17908056] ">Stephan 2007</a>); and risk of progression to dementia (<a href="./references#CD011905-bbs2-0118" title="MatthewsFE , StephanBC , McKeithIG , BondJ , BrayneC . Two‐year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?. Journal of the American Geriatrics Society2008;56(8):1424‐33. ">Matthews 2008</a>). Further subdivisions can be made depending on the suspected underlying cause of the cognitive deficits (e.g. MCI due to AD and MCI due to vascular disease, termed 'vascular cognitive impairment no dementia' (VCIND)). Moreover, attempts have been made to develop new criteria to capture even earlier preclinical states including, for example, 'pre‐MCI' that captures individuals with impaired executive function and language, higher apathy scores, and lower left hippocampal volumes on brain imaging compared to normal controls (<a href="./references#CD011905-bbs2-0089" title="DuaraR , LoewensteinDA , GreigMT , PotterE , BarkerW , RajA , et al. Pre‐MCI and MCI: neuropsychological, clinical, and imaging features and progression rates. American Journal of Geriatric Psychiatry2011;19(11):951‐60. ">Duara 2011</a>). There is no standard definition of MCI universally accepted for use in clinical trials (<a href="./references#CD011905-bbs2-0156" title="StephanBCM , MinettT , PagettE , SiervoM , BrayneC , McKeithIG . Diagnosing mild cognitive impairment (MCI) in clinical trials: a systematic review. BMJ Open2013;3(2):e001909. ">Stephan 2013</a>), but adaptations of the criteria suggested by Petersen are commonly used (<a href="./references#CD011905-bbs2-0136" title="PetersenRC , SmithGE , WaringSC , IvnikRJ , TangalosEG , KokmenE . Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology1999;56(3):303‐8. ">Petersen 1999</a>). </p> <p>Subtypes of dementia are distinguished by the underlying pathology. The four most common subtypes are Alzheimer's disease dementia (AD) (accounting for an estimated 60% to 70% of all dementia cases); vascular dementia (VaD); dementia with Lewy Bodies (DLB); and frontotemporal dementia (FTD). Accurate diagnosis of the subtypes may be difficult. Mixed pathology is common, with more than 80% of cases having some features of Alzheimer’s disease (<a href="./references#CD011905-bbs2-0105" title="JellingerKA . Clinicopathological analysis of dementia disorders in the elderly ‐ an update. Journal of Alzheimer's Disease2006;9(Suppl 3):61‐70. ">Jellinger 2006</a>; <a href="./references#CD011905-bbs2-0165" title="World Health Organization. Dementia: a public health priority. apps.who.int/iris/bitstream/handle/10665/75263/9789241564458_eng.pdf2012. ">WHO 2012</a>). However, the proportion of dementia attributable to Alzheimer’s disease reduces with age (<a href="./references#CD011905-bbs2-0150" title="SavvaGM , WhartonSB , IncePG , ForsterG , MatthewsFE , BrayneC . Age, neuropathology, and dementia. New England Journal of Medicine2009;360(22):2302‐9. ">Savva 2009</a>). </p> </section> <section id="CD011905-sec-0034"> <h4 class="title">Prevalence of MCI and dementia</h4> <p>In the UK Medical Research Council's population‐based Cognitive Function and Ageing Study (CFAS), when 18 different definitions of MCI were mapped, the range of prevalence estimates was found to be highly variable (0.1% to 42.0%), and conversion rates to dementia generally low (<a href="./references#CD011905-bbs2-0155" title="StephanBC , MatthewsFE , McKeithIG , BondJ , BrayneC . Early cognitive change in the general population: how do different definitions work?. Journal of the American Geriatrics Society2007;55(10):1534‐40. [PUBMED: 17908056] ">Stephan 2007</a>). In general, prevalence and conversion rates in specialist settings have been reported to be higher than in population‐based studies (adjusted conversion rate from MCI to dementia 9.6% versus 4.9%) (<a href="./references#CD011905-bbs2-0125" title="MitchellAJ , Shiri‐FeshkiM . Rate of progression of mild cognitive impairment to dementia‐‐meta‐analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica2009;119(4):252‐65. ">Mitchell 2009</a>). </p> <p>The risk of dementia increases with age; according to a World Health Organization (WHO) report, only 2% to 10% of cases start before the age of 65 (<a href="./references#CD011905-bbs2-0165" title="World Health Organization. Dementia: a public health priority. apps.who.int/iris/bitstream/handle/10665/75263/9789241564458_eng.pdf2012. ">WHO 2012</a>). The same report estimated that there were 35.6 million people with dementia in the world in 2010, and that this figure would double every 20 years to reach 65.7 million in 2030 (<a href="./references#CD011905-bbs2-0165" title="World Health Organization. Dementia: a public health priority. apps.who.int/iris/bitstream/handle/10665/75263/9789241564458_eng.pdf2012. ">WHO 2012</a>). However, there is a degree of uncertainty about the expected increase in prevalence of dementia. Recent research in the UK (<a href="./references#CD011905-bbs2-0119" title="MatthewsFE , ArthurA , BarnesLE , BondJ , JaggerC , RobinsonL , et al. A two‐decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet2013;382(9902):1405‐12. ">Matthews 2013</a>) and Denmark (<a href="./references#CD011905-bbs2-0081" title="ChristensenK , ThinggaardM , OksuzyanA , SteenstrupT , Andersen‐RanbergK , JeuneB , et al. Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart. Lancet2013;382(9903):1507‐13. ">Christensen 2013</a>) suggests that the age‐specific prevalence of dementia may be falling in developed countries, supporting the idea that there may be modifiable risk factors. Nevertheless, because of population ageing, the overall prevalence continues to rise. </p> </section> <section id="CD011905-sec-0035"> <h4 class="title">Risk factors</h4> <p>Generally, risk factors for dementia can be divided into modifiable and non‐modifiable factors. The non‐modifiable risk factors include age, genetic factors, family history, gender (females are at higher risk), and Down syndrome. The modifiable factors are smoking, high cholesterol, stroke, hypertension, lack of physical activity, diabetes mellitus, obesity, and low educational level. Among the non‐modifiable risk factors, age has the greatest effect. It has been calculated that in people older than 65, the risk of AD (the commonest cause of dementia) doubles every five years (<a href="./references#CD011905-bbs2-0111" title="LaunerLJ , AndersenK , DeweyME , LetenneurL , OttA , AmaducciLA , et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European studies of dementia. Neurology1999;52(1):78‐84. ">Launer 1999</a>; <a href="./references#CD011905-bbs2-0122" title="McCullaghCD , CraigD , McIlroySP , PassmoreAP . Risk factors for dementia. Advances in Psychiatric Treatment2001;7(1):24‐31. ">McCullagh 2001</a>; <a href="./references#CD011905-bbs2-0161" title="van denBergS , SplaineM . Policy brief risk factors for dementia. Alzheimer's Disease International 2012 Apr [accessed 2014 Sep 19]. ">van den Berg 2012</a>; <a href="./references#CD011905-bbs2-0162" title="van derFlierWM , ScheltensP . Epidemiology and risk factors of dementia. Journal of Neurology, Neurosurgery, and Psychiatry2005;76(Suppl 5):v2–v7. ">van der Flier 2005</a>). A pooled analysis of four prospective studies in Europe found the incidence rate of AD among people aged 90 and over to be 63.5/1000 person‐years (<a href="./references#CD011905-bbs2-0111" title="LaunerLJ , AndersenK , DeweyME , LetenneurL , OttA , AmaducciLA , et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European studies of dementia. Neurology1999;52(1):78‐84. ">Launer 1999</a>). Genetics plays a major role in early onset AD, but a lesser role in the much commoner late onset disease. Epidemiological evidence suggests that many of the modifiable risk factors (diabetes, midlife obesity, midlife hypertension, smoking, and physical inactivity) are risk factors for both AD and vascular disease, including vascular dementia (<a href="./references#CD011905-bbs2-0160" title="The World Alzheimer Report. Dementia and Risk Reduction: An analysis of protective and modifiable factors. London: Alzheimer’s Disease International (ADI), 2014. ">The World Alzheimer Report 2014</a>; <a href="./references#CD011905-bbs2-0165" title="World Health Organization. Dementia: a public health priority. apps.who.int/iris/bitstream/handle/10665/75263/9789241564458_eng.pdf2012. ">WHO 2012</a>). </p> <p>At present, there is no cure for any subtype of dementia, but identifying and targeting modifiable risk factors may offer opportunities to modify its onset and course. Research has been reported suggesting that cognitive stimulation, exercise, diet, and the management of vascular risk factors such as hypertension, diabetes, obesity, smoking, and physical inactivity may have an important role in prevention of AD (<a href="./references#CD011905-bbs2-0112" title="LindsayJ , LaurinD , VerreaultR , HebertR , HelliwellB , HillGB , et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. American Journal of Epidemiology2002;156(5):445‐53. ">Lindsay 2002</a>; <a href="./references#CD011905-bbs2-0115" title="LouridaI , SoniM , Thompson‐CoonJ , PurandareN , LangIA , UkoumunneOC , et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology2013;24(4):479‐89. ">Lourida 2013</a>; <a href="./references#CD011905-bbs2-0126" title="NortonS , MatthewsFE , BarnesDE , YaffeK , BrayneC . Potential for primary prevention of Alzheimer's disease: an analysis of population‐based data. Lancet Neurology2014;13(8):788‐94. ">Norton 2014</a>; <a href="./references#CD011905-bbs2-0166" title="WilsonRS , BennettDA , BieniasJL , AggarwalNT , Mendes De LeonCF , MorrisMC , et al. Cognitive activity and incident AD in a population‐based sample of older persons. Neurology2002;59(12):1910‐4. ">Wilson 2002</a>). There is also some evidence in support of vitamin supplementation as a preventive strategy. For example, vitamin B12 and folate lower levels of homocysteine, which is believed to be toxic to neurones. Protective effects of vitamin D and vitamin E against AD have also been proposed (<a href="./references#CD011905-bbs2-0071" title="AnnweilerC , RollandY , SchottAM , BlainH , VellasB , HerrmannFR , et al. Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7‐year follow‐up. Journals of Gerontology: Series A Biological Sciences and Medical Sciences2012;67(11):1205‐11. ">Annweiler 2012</a>; <a href="./references#CD011905-bbs2-0091" title="DyskenMW , SanoM , AsthanaS , VertreesJE , PallakiM , LlorenteM , et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM‐AD VA cooperative randomized trial. JAMA2014;311(1):33‐44. ">Dysken 2014</a>; <a href="./references#CD011905-bbs2-0114" title="LlewellynDJ , LangIA , LangaKM , Muniz‐TerreraG , PhillipsCL , CherubiniA , et al. Vitamin D and risk of cognitive decline in elderly persons. Archives of Internal Medicine2010; Vol. 170, issue 13:1135‐41. ">Llewellyn 2010</a>). Many minerals might have antioxidant properties and may also be beneficial in protecting against oxidative stress and free radical damage. Hence, an evaluation of the role of vitamins and minerals as protective and preventive agents in cognitive impairment is warranted (see <a href="./appendices#CD011905-sec-0154">Appendix 1</a>). </p> </section> </section> <section id="CD011905-sec-0036"> <h3 class="title" id="CD011905-sec-0036">Description of the intervention</h3> <p>This review focusses on RCTs investigating the effect of vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. Vitamins are organic compounds that are essential for the normal physiological process in the body and play important roles in growth and development (<a href="./references#CD011905-bbs2-0108" title="KennedyDO , HaskellCF . Vitamins and cognition: what is the evidence?. Drugs2011;71(15):1957‐71. ">Kennedy 2011</a>). Minerals are inorganic elements that come from the earth; as nutrients, they have similar essential roles in normal physiology (<a href="./references#CD011905-bbs2-0080" title="Centers for Disease Control and Prevention. Vitamins and minerals. https://www.cdc.gov/nutrition/index.html (accessed prior to 28 September 2018). ">Centers for Disease Control and Prevention 2014</a>). All of these essential nutrients are available naturally in food, although deficiencies can occur due to inadequate dietary intake or a variety of disease states. Dietary supplements are any consumed products that aim to provide additional nutrients to those obtained from the usual diet. </p> </section> <section id="CD011905-sec-0037"> <h3 class="title" id="CD011905-sec-0037">How the intervention might work</h3> <p>Vitamins and minerals have multiple important roles in the physiology of the human body at cellular and tissue levels. Putative biological mechanisms for each are summarised briefly in <a href="./appendices#CD011905-sec-0154">Appendix 1</a>. </p> <p>There is a complex array of micronutrients which protect the brain in a variety of ways, including protection against damaging oxygen‐free radicals, and which are important in neurogenesis, gene expression, and enzyme and receptor control (<a href="./references#CD011905-bbs2-0138" title="PowellSR . The antioxidant properties of zinc. Journal of Nutrition2000;130(Suppl 55):1447S‐54S. ">Powell 2000</a>). Failure of these important systems appears to be implicated in the occurrence of neural damage (<a href="./references#CD011905-bbs2-0163" title="van derSchaftJ , KoekHL , DijkstraE , VerhaarHJ , van derSchouwYT , Emmelot‐VonkMH . The association between vitamin D and cognition: A systematic review. Ageing Research Reviews2013;12(4):1013‐23. ">van der Schaft 2013</a>). Therefore, ensuring adequate vitamin and mineral levels in the body might enhance cognitive function. </p> <p>Oxidative stress has been shown to be a damaging process leading to an imbalance between oxygen‐free radicals, and the anti‐oxidative defences and repair of oxidative damage to proteins, lipids, RNA, and DNA (<a href="./references#CD011905-bbs2-0098" title="HalliwellB . Reactive oxygen species and the central nervous system. Journal of Neurochemistry1992;59(5):1609‐23. ">Halliwell 1992</a>; <a href="./references#CD011905-bbs2-0099" title="HalliwellB . Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radical Research1999;31(4):261‐72. ">Halliwell 1999</a>; <a href="./references#CD011905-bbs2-0157" title="TabetN , MantleD , WalkerZ , OrrelM . Vitamins, trace elements, and antioxidant status in dementia disorders. International Psychogeriatrics2001;13(3):265‐75. ">Tabet 2001</a>; <a href="./references#CD011905-bbs2-0158" title="TabetN , MantleD , WalkerZ , OrrellM . Endogenous antioxidant activities in relation to concurrent vitamins A, C, and E intake in dementia. International Psychogeriatrics2002;14(1):7‐15. ">Tabet 2002</a>). In addition, the central nervous system (CNS) contains high levels of unsaturated fatty acids that are substrates for peroxidation reactions (<a href="./references#CD011905-bbs2-0129" title="OgawaN . Free radicals and neural cell damage. Rinsho Shinkeigaku1994;34(12):1266‐8   . ">Ogawa 1994</a>). An important defence mechanism in the brain involves enzymatic antioxidants which, if mediated through the supplementation of micronutrients, may replenish the brain with synthetic antioxidants providing a therapeutic approach to reduce oxidative stress (<a href="./references#CD011905-bbs2-0144" title="ReiterRJ . Oxidative processes and antioxidative defence mechanisms in the ageing brain. FASEB journal : official publication of the Federation of American Societies for Experimental Biology1995;9(7):526‐33. ">Reiter 1995</a>). This may be a useful adjunct in modifying risk factors in the pathogenesis of neurodegenerative disorders (<a href="./references#CD011905-bbs2-0133" title="PackerL , TritschlerH J , WesselK . Neuroprotection by the metabolic antioxidant a‐lipoic acid. Free Radical Biology and Medicine1997;22(1‐2):359‐78     . ">Packer 1997</a>). </p> <section id="CD011905-sec-0038"> <h4 class="title">Vitamins:</h4> <p>Vitamins have a wide range of roles in the central nervous system and hence may affect the pathophysiological processes underlying the dementias in numerous different ways. Vitamin A may be involved in the stabilisation of beta amyloid fibrils (<a href="./references#CD011905-bbs2-0130" title="OnoK , YamadaM . Vitamin A and Alzheimer's disease. Geriatrics &amp; Gerontology International2012;12(2):180‐8. ">Ono 2012</a>). Vitamin D is a precursor of hormones required for calcium and phosphorus metabolism and also has a possible role in cognition in older adults (<a href="./references#CD011905-bbs2-0141" title="PrzybelskiRJ , BinkleyNC . Is vitamin D important for preserving cognition? A positive correlation of serum 25‐hydroxyvitamin D concentration with cognitive function. Archives of Biochemistry and Biophysics2007;460(2):202‐5. ">Przybelski 2007</a>). Vitamin E is an antioxidant which provides protection against free radical damage (<a href="./references#CD011905-bbs2-0092" title="FarinaN , IsaacMG , ClarkAR , RustedJ , TabetN . Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database of Systematic Reviews2012, Issue 11. [DOI: 10.1002/14651858.CD002854.pub3] ">Farina 2012</a>; <a href="./references#CD011905-bbs2-0159" title="TakatsuH , OwadaK , AbeK , NakanoM , UranoS . Effect of vitamin E on learning and memory deficit in aged rats. Journal of Nutritional Science and Vitaminology2009;55(5):389‐93. ">Takatsu 2009</a>). B vitamins, particularly vitamin B12 and folic acid, have a role in energy production and metabolism within the CNS. B vitamins have also been implicated in the production of nucleic acids and production and maintenance of myelin essential for good neuronal health (<a href="./references#CD011905-bbs2-0109" title="KühnastS , LouweMC , HeemskerkMM , PietermanEJ , vanKlinkenJB , van denBergSA , et al. Niacin reduces atherosclerosis development in APOE*3Leiden. CETP mice mainly by reducing nonHDL‐cholesterol. PLoS One2013;8(6):e66467. ">Kühnast 2013</a>; <a href="./references#CD011905-bbs2-0131" title="OsiezaghaK , AliS , FreemanC , BarkerN C , JabeenS , MaitraS , et al. Thiamine deficiency and delirium. Innovations in Clinical Neuroscience2013;10(4):26‐32. ">Osiezagha 2013</a>; <a href="./references#CD011905-bbs2-0134" title="PawlakR , LesterSE , BabatundeT . The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature. European Journal of Clinical Nutrition2014;68(5):541‐8. ">Pawlak 2014</a>; <a href="./references#CD011905-bbs2-0139" title="PowersHJ . Riboflavin (vitamin B‐2) and health. American Journal of Clinical Nutrition2003;77(6):1352‐60. ">Powers 2003</a>; <a href="./references#CD011905-bbs2-0160" title="The World Alzheimer Report. Dementia and Risk Reduction: An analysis of protective and modifiable factors. London: Alzheimer’s Disease International (ADI), 2014. ">The World Alzheimer Report 2014</a>). See <a href="./appendices#CD011905-sec-0154">Appendix 1</a> for more detail of possible mechanisms. </p> </section> <section id="CD011905-sec-0039"> <h4 class="title">Minerals:</h4> <p>Minerals, similarly, have a very wide range of functions. For example, some may be involved in neuronal gene expression and the secretion of neurotransmitters (<a href="./references#CD011905-bbs2-0132" title="OzawaM , NinomiyaT , OharaT , HirakawaY , DoiY , HataJ , et al. Self‐reported dietary intake of potassium, calcium, and magnesium and risk of dementia in the Japanese: the Hisayama study. Journal of the American Geriatrics Society2012;60(8):1515‐20. ">Ozawa 2012</a>; <a href="./references#CD011905-bbs2-0054" title="RossomRC , EspelandMA , MansonJE , DyskenMW , JohnsonKC , LaneDS , et al. Calcium and vitamin D supplementation and cognitive impairment in the Women's Health Initiative. Journal of the American Geriatrics Society2012;60(12):2197‐205. ">Rossom 2012</a>). Potassium, calcium, and magnesium were reported to be protective against cognitive decline in a cohort of Japanese participants (<a href="./references#CD011905-bbs2-0132" title="OzawaM , NinomiyaT , OharaT , HirakawaY , DoiY , HataJ , et al. Self‐reported dietary intake of potassium, calcium, and magnesium and risk of dementia in the Japanese: the Hisayama study. Journal of the American Geriatrics Society2012;60(8):1515‐20. ">Ozawa 2012</a>). Selenium is a critical component of the enzyme glutathione peroxidase and has been shown to protect the CNS and immune system from oxidative damage by harmful free radicals (<a href="./references#CD011905-bbs2-0075" title="BerrC , ArnaudJ , AkbaralyTN . Selenium and cognitive impairment: a brief‐review based on results from the EVA study. BioFactors2012; Vol. 38, issue 2:139‐44. ">Berr 2012</a>; <a href="./references#CD011905-bbs2-0123" title="MehdiY , HornickJL , IstasseL , DufrasneI . Selenium in the environment, metabolism and involvement in body functions. Molecules2013;18(3):3292–3311. ">Mehdi 2013</a>; <a href="./references#CD011905-bbs2-0152" title="SmorgonC , MariE , AttiAR , Dalla NoraE , ZamboniPF , CalzoniF , et al. Trace elements and cognitive impairment: an elderly cohort study. Archives of Gerontology and Geriatrics2004;38(Suppl 9):393‐402. ">Smorgon 2004</a>). See <a href="./appendices#CD011905-sec-0154">Appendix 1</a> for more detail of possible mechanisms. </p> <p>Micronutrients may not be maximally effective if supplemented in isolation. There are some patented formulas consisting of complex mixtures of micronutrients which are claimed to work synergistically. These are sometimes marketed as licensed medical foods. These licensed medical foods are not covered in this set of reviews. </p> </section> </section> <section id="CD011905-sec-0040"> <h3 class="title" id="CD011905-sec-0040">Why it is important to do this review</h3> <p>The prevalence and financial implications of dementia are such that small effects on cognitive decline or on the incidence of dementia may have a large impact on healthcare costs and the overall burden of dementia. Robust assessments are needed of the effect size of interventions and of the ‘dose’ and duration of intervention necessary to achieve an effect. </p> <p>For individuals, fear of cognitive decline and dementia may be a powerful motivator to seek preventive interventions. Nutritional supplements and cognitive activities (e.g. computerised 'brain training' games), in particular, are subject to promotion by those with commercial interests. It is important for people to know whether time, effort, and money they might invest to prevent cognitive decline is likely to be well spent. Information about adverse effects is also important. Although nutritional and behavioural interventions are often perceived to be ‘low risk’, they are not necessarily without the potential to cause harm. For example, trials have found high doses of vitamin E to be associated with more adverse effects than placebo (<a href="./references#CD011905-bbs2-0076" title="BjelakovicG , NikolovaD , GluudLL , SimonettiRG , GluudC . Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD007176.pub2] ">Bjelakovic 2012</a>; <a href="./references#CD011905-bbs2-0078" title="Brigelius‐FloheR . Adverse effects of vitamin E by induction of drug metabolism. Genes &amp; Nutrition2007;2(3):249‐56. [PUBMED: 18850180] ">Brigelius‐Flohe 2007</a>; <a href="./references#CD011905-bbs2-0124" title="MillerER3rd , Pastor‐BarriusoR , DalalD , RiemersmaRA , AppelLJ , GuallarE . Meta‐analysis: high‐dosage vitamin E supplementation may increase all‐cause mortality. Annals of Internal Medicine2005;142(1):37‐46. ">Miller 2005</a>). </p> <p>People with MCI are interested in interventions which could prevent or delay further cognitive decline. In addition, this review will be of interest to clinicians providing care for people with MCI and to policy makers. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011905-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011905-sec-0041">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011905-sec-0186">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011905-sec-0041"></div> <p>To evaluate the effects of vitamin and mineral supplementation on cognitive function and the incidence of dementia in people with mild cognitive impairment. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011905-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011905-sec-0042">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011905-sec-0187">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011905-sec-0042"></div> <section id="CD011905-sec-0043"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011905-sec-0044"> <h4 class="title">Types of studies</h4> <p>We included in the review randomised or quasi‐randomised controlled trials, published or unpublished, reported in any language. We included studies involving both randomised and non‐randomised trial arms, but we only considered results from the former. We included cross‐over studies, but extracted and analysed data from the first treatment period only. </p> </section> <section id="CD011905-sec-0045"> <h4 class="title">Types of participants</h4> <p>We included the following population: people diagnosed with mild cognitive impairment (MCI) according to internationally accepted and validated criteria. We recorded definitions. Participants should have been reported to be free of dementia at baseline. Consequently, we included only trials which assessed cognitive function or dementia status with internationally accepted and validated instruments at baseline and follow‐up. </p> <p>We excluded trials of participants with severe vitamin or mineral deficiency where the intervention given could correct these deficiencies. </p> </section> <section id="CD011905-sec-0046"> <h4 class="title">Types of interventions</h4> <p>We included studies comparing the effects of the described vitamin and mineral supplements with control interventions that were not expected to have specific risk‐modifying effects. The control arms typically involved placebo or no intervention/usual care. The minimum treatment duration was set at 12 weeks. Experimental interventions could be single vitamin or mineral supplements or combination treatments with any of the supplements listed in <a href="./appendices#CD011905-sec-0154">Appendix 1</a>. We excluded trials of vitamins or minerals given in combination with other unrelated compounds (e.g. amino acids, fatty acids, or medications) unless the effects of the vitamins and minerals could be isolated. For example, a trial evaluating the effects of vitamin A and C versus methionine would have been excluded, whereas a trial evaluating vitamin A and C with methionine versus methionine only would have been included. We included only orally‐administered supplements. There were no restrictions on dose. </p> </section> <section id="CD011905-sec-0047"> <h4 class="title">Types of outcome measures</h4> <section id="CD011905-sec-0048"> <h5 class="title">Primary outcomes</h5> <p>1. The incidence of all‐cause dementia (assessed using internationally accepted and validated criteria). </p> <p>The main time point of interest was end of trial, defined as the time point with the longest follow‐up duration as measured from randomisation (see also section, <a href="#CD011905-sec-0056">Data extraction and management</a>). Outcome data reported at other time points after randomisation were extracted and presented. For this outcome, the minimum follow‐up period was 12 months. </p> <p>2. Overall cognitive functioning, measured with, for example, Alzheimer's Disease Assessment Scale‐cognitive subscale (ADAS‐cog); the Mini Mental State Examination (MMSE); Repeatable Battery for the Assessment of Neuropsychological Status (RBANS); Cambridge Cognition Examination (CAMCOG). </p> </section> <section id="CD011905-sec-0049"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes were any internationally accepted and validated measures of:</p> <p>‐ specific cognitive functioning subdomain: episodic memory,</p> <p>‐ specific cognitive functioning subdomain: executive functioning,</p> <p>‐ specific cognitive functioning subdomain: speed of processing,</p> <p>‐ quality of life, either generic or disease‐specific,</p> <p>‐ clinical global impression,</p> <p>‐ functional performance,</p> <p>‐ number of participants experiencing one or more serious adverse events (SAE),</p> <p>‐ mortality.</p> <p>‐ biomarkers: where studies included validated biomarkers (e.g., beta‐amyloid or tau in cerebrospinal fluid, structural MRI or amyloid imaging) as well as cognitive outcomes, biomarker data were extracted. </p> <section id="CD011905-sec-0050"> <h6 class="title">Outcomes included in the 'Summary of findings' table</h6> <p>Critical effectiveness outcomes included in the 'Summary of findings' table for this review were incidence of dementia, all outcomes related to cognitive functioning, quality of life, and mortality. </p> </section> </section> </section> </section> <section id="CD011905-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011905-sec-0052"> <h4 class="title">Electronic searches</h4> <p>We searched ALOIS (www.medicine.ox.ac.uk/alois), the Cochrane Dementia and Cognitive Improvement Group’s (CDCIG) specialised register on 25 January 2018. </p> <p>ALOIS is maintained by the Information Specialists for the CDCIG, and contains studies that fall within the areas of dementia prevention, dementia treatment and management, and cognitive enhancement in healthy elderly populations. The studies are identified through: </p> <p> <ol id="CD011905-list-0001"> <li> <p>Monthly searches of a number of major healthcare databases: MEDLINE, Embase, CINAHL, PsycINFO and LILACS; </p> </li> <li> <p>Monthly searches of a number of trial registers: ISRCTN; UMIN (Japan's Trial Register); the WHO portal (which covers ClinicalTrials.gov; ISRCTN; the Chinese Clinical Trials Register; the German Clinical Trials Register; the Iranian Registry of Clinical Trials, and the Netherlands National Trials Register, plus others); </p> </li> <li> <p>Quarterly search of the Cochrane Library's Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>Six‐monthly searches of a number of grey literature sources: ISI Web of Science Core Collection; Index to Theses; Australasian Digital Theses. </p> </li> </ol> </p> <p>To view a list of all sources searched for ALOIS, see 'About ALOIS' on the ALOIS website (www.medicine.ox.ac.uk/alois). </p> <p>Details of the search strategies run in healthcare bibliographic databases, used for the retrieval of reports of dementia, cognitive improvement, and cognitive enhancement trials, can be viewed in the ‘methods used in reviews’ section within the editorial information about the Cochrane Dementia and Cognitive Improvement Group. </p> <p>We ran additional searches in MEDLINE, Embase, PsycINFO, CENTRAL, CINAHL, Web of Science Core Collection, LILACs, ClinicalTrials.gov, and the WHO Portal/ICTRP to ensure that the searches for each suite of reviews was as comprehensive and as up‐to‐date as possible to identify published, unpublished, and ongoing trials. The search strategies used for the retrieval of reports of trials can be seen in <a href="./appendices#CD011905-sec-0155">Appendix 2</a>. </p> </section> <section id="CD011905-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We screened reference lists of all included trials. In addition, we screened reference lists of recent systematic reviews, health technology assessment reports, and subject‐specific guidelines identified through www.guideline.gov. The search was restricted to those guidelines meeting the 2013 inclusion criteria of the National Guideline Centre (NGC), published in this year or later. </p> <p>We contacted experts in the field and companies marketing included interventions, in order to provide additional randomised trial reports that were not identified by the search. </p> </section> </section> <section id="CD011905-sec-0054"> <h3 class="title" id="CD011905-sec-0054">Data collection and analysis</h3> <p>We used this protocol, alongside instructions for data extraction, quality assessment, and statistical analyses which were based on a generic protocol generated by the editorial board of CDCIG to guide this and another 11 reviews on modifiable risk factors (see <a href="#CD011905-sec-0151">Acknowledgements</a>). </p> <section id="CD011905-sec-0055"> <h4 class="title">Selection of studies</h4> <p>If multiple reports described the same trial, we included all to allow complete extraction of the trial details. </p> <p>We used crowdsourcing to screen the search results. Details of this method have been described here (<a href="http://www.medicine.ox.ac.uk/alois/content/modifiable-risk-factors" target="_blank">http://www.medicine.ox.ac.uk/alois/content/modifiable‐risk‐factors</a>). In brief, teams of volunteers performed a ‘first assess’ on the search results. The volunteers were recruited through the author team’s institutions. They screened the results using an online tool developed for Cochrane Embase project but tailored for this programme of work. The crowd decided, based on a reading of title and abstract, whether the citation was describing a randomised or quasi‐randomised trial, irrespective of the citations topic. The citations identified as possibly relevant by the crowd were then screened by the author team. </p> </section> <section id="CD011905-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>Two review authors, working independently, extracted trial information using a standardised and piloted extraction method, referring also to a guidance document. Discrepancies were resolved by discussion, or by the involvement of a third reviewer. Where possible, we extracted (as a minimum) the following information related to characteristics of participants, intervention, and study design: </p> <section id="CD011905-sec-0057"> <h5 class="title">Participant characteristics</h5> <p> <ul id="CD011905-list-0002"> <li> <p>gender</p> </li> <li> <p>baseline age (range, median, mean)</p> </li> <li> <p>education (level and years of education)</p> </li> <li> <p>baseline cognitive function</p> </li> <li> <p>cognitive diagnostic status</p> </li> <li> <p>duration of cognitive symptoms, if any</p> </li> <li> <p>ethnicity</p> </li> <li> <p>Apo‐E genotype</p> </li> <li> <p>diabetes mellitus (yes/no)</p> </li> <li> <p>physical activity (as defined by the trialists).</p> </li> <li> <p>smoking (never/ever)</p> </li> </ul> </p> </section> <section id="CD011905-sec-0058"> <h5 class="title">Intervention characteristics</h5> <p> <ul id="CD011905-list-0003"> <li> <p>nature of the intervention/generic and trade name of intervention</p> </li> <li> <p>description of the control condition</p> </li> <li> <p>duration of treatment</p> </li> <li> <p>dosage and frequency</p> </li> <li> <p>any concomitant treatments</p> </li> <li> <p>treatment adherence</p> </li> </ul> </p> </section> <section id="CD011905-sec-0059"> <h5 class="title">Methodological characteristics</h5> <p> <ul id="CD011905-list-0004"> <li> <p>trial design (individual or cluster randomisation; parallel group, factorial or cross‐over design) </p> </li> <li> <p>number of participants</p> </li> <li> <p>outcome measures used</p> </li> <li> <p>duration of follow‐up, as measured from randomisation</p> </li> <li> <p>duration of follow‐up, as measured from end of treatment</p> </li> <li> <p>source of financial support</p> </li> <li> <p>publication status</p> </li> </ul> </p> <p>If secondary outcome data were available at multiple time‐points within a given trial, we grouped them as follows: immediate (up to 12 weeks), short‐term (up to one year), medium‐term (one to two years) and longer‐term results (more than two years). For the primary outcome (all‐cause dementia), we considered only outcome data at one year of follow‐up or longer. Within these time periods, we extracted the latest available data reported by the study. For example, if a study reported data at six months, nine months and one year, we extracted and analysed only the one‐year data for the one‐year (short‐term) time point. </p> <p>For dichotomous outcomes (such as incident dementia or mortality), we extracted from each trial the number of participants with each outcome at each time point. </p> <p>For continuous outcomes, we extracted the number of participants in whom the outcome was measured, and the mean and standard deviation of the change from baseline for each outcome at each time point. If change‐from‐baseline data were not available, we extracted the mean value at each time point. When necessary, means and measures of dispersion were approximated from figures in the reports. </p> <p>Whenever possible, we extracted intention‐to‐treat data, i.e. analysing all participants according to the group randomisation; if this was not available, then we extracted and reported data from available case analyses<i>.</i> If neither of these types of data were available, we considered data from 'per protocol' analyses. We contacted the trialists if we were unable to obtain the necessary data from the trial report. </p> </section> </section> <section id="CD011905-sec-0060"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>After completion of a standardised training session provided by AR, one member of the author team and one experienced reviewer provided by the editorial team independently assessed the risk of bias in each of the included trials using the Cochrane's 'Risk of bias' tool (<a href="./references#CD011905-bbs2-0101" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We resolved disagreements by consensus. We assessed the risk of bias potentially introduced by suboptimal design choices with respect to sequence generation, concealment of allocation, blinding of participants and caregivers, blinded outcome assessment, selective outcome reporting, and incomplete outcome data, including the type of statistical analyses used (true intention‐to‐treat versus other analyses). The general definitions that were used are reported in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011905-bbs2-0101" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD011905-sec-0061"> <h4 class="title">Measures of treatment effect</h4> <p>We expressed the measure of treatment effect for continuous outcomes as a mean difference if all included studies used the same outcome measure and as a standardised mean difference (SMD), defined as the between‐group difference in mean values divided by the pooled standard deviation (SD), if the same outcome was assessed with a variety of measurement scales. We expressed the treatment effect for dichotomous outcomes as a relative risk (RR). </p> </section> <section id="CD011905-sec-0062"> <h4 class="title">Unit of analysis issues</h4> <p>We did not identify any cross‐over or cluster‐randomised trials for inclusion.</p> </section> <section id="CD011905-sec-0063"> <h4 class="title">Dealing with missing data</h4> <p>Missing data in individual trials may put the study estimates of effects at a high risk of bias, and may lower the overall quality of the evidence according to GRADE (<a href="./references#CD011905-bbs2-0101" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We dealt with missing data in our 'Risk of bias' assessments and evaluated attrition bias in stratified analyses of the primary outcomes (<a href="./appendices#CD011905-sec-0155">Appendix 2</a>). We analysed the available information and did not contact authors with a request to provide missing information; nor did we impute missing data ourselves. </p> </section> <section id="CD011905-sec-0064"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined heterogeneity in stratified analyses by trial, participant, and intervention characteristics, as outlined in the sections <a href="./references#CD011905-sec-0152" title="">Data and analyses</a> and <a href="./appendices#CD011905-sec-0155">Appendix 2</a>. </p> </section> <section id="CD011905-sec-0065"> <h4 class="title">Assessment of reporting biases</h4> <p>We identified too few trials to allow the use of funnel plots to explore reporting biases or other small study effects. </p> </section> <section id="CD011905-sec-0066"> <h4 class="title">Data synthesis</h4> <p>We examined participants, interventions, and outcomes in the included trials in order to decide whether they were sufficiently similar for data to be pooled. </p> <p>Where we considered it appropriate to pool data, we used standard inverse‐variance random‐effects meta‐analysis to combine outcome data across the trials at the end of trials (<a href="./references#CD011905-bbs2-0087" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. ">DerSimonian 1986</a>); and, if possible, at least one additional time point (see <a href="#CD011905-sec-0048">Primary outcomes</a> and <a href="#CD011905-sec-0056">Data extraction and management</a> for definitions of time points). We visually inspected forest plots for the presence of heterogeneity and calculated the variance estimate tau² as a measure of between‐trial heterogeneity (<a href="./references#CD011905-bbs2-0087" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. ">DerSimonian 1986</a>). We prespecifed a Tau² of 0.04 to represent low heterogeneity, 0.09 to represent moderate heterogeneity, and 0.16 to represent high heterogeneity between trials (<a href="./references#CD011905-bbs2-0154" title="SpiegelhalterDJ , AbramsKJ , MylesJP . Bayesian Approaches to Clinical Trials and Health‐Care Evaluation. Chichester, UK: J Wiley, 2004. ">Spiegelhalter 2004</a>). We also presented the I² statistic and the corresponding Chi² test (<a href="./references#CD011905-bbs2-0100" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). I² describes the percentage of variation across trials attributable to heterogeneity rather than to chance, with values of 25%, 50%, and 75% typically being interpreted as low, moderate, and high between‐trial heterogeneity. We preferred Tau² over I² in the interpretation of between‐trial heterogeneity, as the interpretation of I² can be largely affected by the precision of trials included in the meta‐analysis (<a href="./references#CD011905-bbs2-0149" title="RückerG , SchwarzerG , CarpenterJR , SchumacherM . Undue reliance on I2 in assessing heterogeneity may mislead. BMC Medical Research Methodology2008;8(1):79. ">Rücker 2008</a>). We did statistical analyses in Review Manager 5 (<a href="./references#CD011905-bbs2-0145" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and in STATA, release 13 (StataCorp, College Station, Texas). </p> </section> <section id="CD011905-sec-0067"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had prespecified the following trial characteristics as of interest for exploring possible heterogeneity: concealment of allocation, blinding of participants, blinded outcome assessment, intention‐to‐treat analysis, trial size (based on power calculation for trial primary outcome), duration of treatment (&lt;3, 3‐12, &gt;12 months), and length of follow‐up from randomisation (&lt;3 months, 3‐12 months, &gt;1‐2 years, &gt;2 years). We had also prespecified the following possible clinical effect modifiers: age (40‐65 or &gt;65 years), comorbidities, concomittant medications, and ethnicity (<a href="http://archie.cochrane.org/sections/documents/view?document=z1408121416084139023517176204692%26format=REVMAN#REF-Dawson_x002d_Hughes-2004" target="_blank">Dawson‐Hughes 2004</a>). However, too few studies were included to allow us to conduct subgroup analyses or explore the effect of these features. Because B vitamins may work by lowering homocysteine levels and therefore may be more effective in participants with high homocysteine levels at baseline, we decided to amend the protocol to report the effects of B vitamins in subgroups of participants distinguished by level of homocysteine at baseline, where this was reported in the included studies (see <a href="#CD011905-sec-0169">Differences between protocol and review</a>). </p> </section> <section id="CD011905-sec-0068"> <h4 class="title">Sensitivity analysis</h4> <p>We had prespecified a sensitivity analysis for the primary effectiveness outcome, including high‐quality trials only. However, too few trials were included for this to be done. </p> <section id="CD011905-sec-0069"> <h5 class="title">GRADE and summary of findings table</h5> <p>We used GRADE to describe the quality of the overall body of evidence for each outcome in the 'Summary of findings' table (<a href="./references#CD011905-bbs2-0101" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>; <a href="./references#CD011905-bbs2-0097" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. ">Guyatt 2008</a>). </p> <p>Quality in GRADE is defined as the degree of confidence which can be placed in the estimates of treatment benefits and harms. There are four possible ratings: 'high', 'moderate', 'low' and 'very low'. Rating evidence as 'high‐quality' implies that we are confident in our estimate of the effect, and further research is very unlikely to change this. A rating of 'very‐low' quality implies that we are very uncertain about the obtained summary estimate of the effect. </p> <p>The GRADE approach rates evidence from RCTs which do not have serious limitations as 'high‐quality'. However, several factors can lead to the downgrading of the evidence to 'moderate', 'low' or 'very low'. The degree of downgrading is determined by the seriousness of these factors: study limitations (risk of bias); inconsistency; indirectness of evidence; imprecision; and publication bias (<a href="./references#CD011905-bbs2-0101" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>; <a href="./references#CD011905-bbs2-0097" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. ">Guyatt 2008</a>; <a href="./references#CD011905-bbs2-0017" title="ChandraRK . Effect of vitamin and trace‐element supplementation on cognitive function in elderly subjects. Nutrition2001;17(9):709‐12 [Retraction in: Nutrition 2005; 21(2):286]. ">Chandra 2001</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011905-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011905-sec-0070"></div> <section id="CD011905-sec-0071"> <h3 class="title">Description of studies</h3> <section id="CD011905-sec-0072"> <h4 class="title">Results of the search</h4> <p>We conducted searches in December 2014, July 2015, March 2016, August 2016, March 2017, and January 2018. In total, we retrieved 7,257 records from the six searches. After de‐duplication, 5211 records remained. A Crowd and the CDCIG information specialist assessed these at title and abstract level. In total, 725 results remained after this assessment. The review team then screened these records. Of these, we assessed 110 full‐text articles describing 67 trials for eligibility and included eight trials in the review (one after the authors provided subgroup data). Three trials, one described in three papers, were placed in the section 'Awaiting classification'; we sought information from the authors of these trials but received none. We identified one ongoing study of vitamin D supplementation which was due to be completed in July 2018. This process is depicted in <a href="#CD011905-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011905-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011905-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011905-sec-0073"> <h4 class="title">Included studies</h4> <p>We identified eight studies eligible for inclusion in this review. For full details see <a href="./references#CD011905-sec-0171" title="">Characteristics of included studies</a>. </p> <p>We grouped the studies into four comparisons. Five studies compared B vitamins to placebo (<a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>, <a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a>, <a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a>, <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a>, <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>). One study compared vitamin E to placebo (<a href="./references#CD011905-bbs2-0006" title="BlackerD . Neither vitamin E nor donepezil delays progression from amnestic mild cognitive impairment to Alzheimer's disease in the long term. Evidence‐Based Mental Health2006;9(1):20. FleisherAS , SowellBB , TaylorC , GamstAC , PetersenRC , ThalLJ , et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology2007;68(19):1588‐95. GrundmanM . Vitamin E and Alzheimer disease: the basis for additional clinical trials. The American Journal of Clinical Nutrition February 1, 2000;71(2):630S‐636S. PetersenR , GrundmanM , ThomasR , ThalL . Donepezil and vitamin E as treatments for mild cognitive impairment. Neurobiology of Aging2004;25(Supplement 2):S20. PetersenRC , ThomasRG , GrundmanM , BennettD , DoodyR , FerrisS , et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. The New England journal of medicine2005;352(23):2379‐88. ">Petersen 2005</a>), one compared vitamin E + vitamin C to placebo (<a href="./references#CD011905-bbs2-0005" title="NaeiniAM , ElmadfaI , DjazayeriA , BarekatainM , AghayeghazviniMR , JalaliM , et al. Effect of vitamin E and C supplementation on elderly with mild cognitive impairment (MCI) in Isfahan, Iran. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):1145. NaeiniAM , ElmadfaI , DjazayeryA , BarekatainM , GhazviniMR , DjalaliM , et al. The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double‐blind, randomized, placebo‐controlled trial. European Journal of Nutrition2014;53(5):1255‐62. ">Naeini 2014</a>), and one compared chromium picolinate to placebo (<a href="./references#CD011905-bbs2-0004" title="KrikorianR , EliassenJC , BoespflugEL , NashTA , ShidlerMD . Improved cognitive‐cerebral function in older adults with chromium supplementation. Nutritional Neuroscience2010;13(3):116‐22. ">Krikorian 2010</a>). </p> <p><a href="./appendices#CD011905-sec-0156">Appendix 3</a> shows the supplement doses used in the studies in relation to the mean daily intake from food and the recommended daily intake for adults in the UK. </p> <section id="CD011905-sec-0074"> <h5 class="title">Comparison 1: B vitamins versus placebo ‐ description of studies</h5> <p>Five studies with 879 randomised participants contributed data to this comparison.</p> <section id="CD011905-sec-0075"> <h6 class="title">Setting</h6> <p>The studies were conducted in the UK, the Netherlands (2 studies), China and Singapore. <a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a> included participants living in the community or in a care home; participants in all other studies were resident in the community. </p> </section> <section id="CD011905-sec-0076"> <h6 class="title">Participants</h6> <p>All studies specifically excluded participants with dementia. <a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>, <a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a> and <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a> used broadly similar criteria for MCI, which included a memory complaint and scores within a specified range on scales of cognition and daily functioning. Participants in <a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a> had a Clinical Dementia Rating (CDR) global score of 0 or 0.5; for this review we, used data from the participants with a CDR score of 0.5. All participants in <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> had recent lacunar stroke and cognitive impairment ‐ no dementia (CIND); the cognitive impairment was defined as scoring at least 1.5 SDs below expected in at least one domain of a neuropsychological test battery. </p> <p>All participants in <a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a> met the authors' criteria for mild B12 deficiency. </p> <p>Four studies had age‐based inclusion criteria: <a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> and <a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a> only included participants aged 70 or older, <a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a> only included participants aged 60 to 75 years, and <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a> included participants aged 70 to 80 years. Across all studies, the mean age of participants ranged from approximately 66 years (<a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a>) to approximately 80 years (<a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a>). </p> </section> <section id="CD011905-sec-0077"> <h6 class="title">Interventions</h6> <p>All studies were placebo‐controlled. The experimental interventions varied in composition and dose. </p> <p> <ul id="CD011905-list-0005"> <li> <p>Participants in <a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> received 0.5 mg B12 + 0.8 mg folic acid + 20 mg B6 once daily for two years. </p> </li> <li> <p><a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a> was a three‐arm study. For this review, we combined the groups receiving 1 mg B12 and 1 mg B12 + 0.4 mg folic acid into a single experimental intervention group. Treatment was once daily for 24 weeks. </p> </li> <li> <p>Participants in <a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a> received 0.4 mg folic acid once daily for six months. </p> </li> <li> <p>Participants in <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> received 0.5 mg B12 + 2 mg folic acid + 25 mg B6 once daily for one to five years. </p> </li> <li> <p>Participants in <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a> received 0.4 mg vitamin B12 + 5 mg folic acid + 50 mg vitamin B6 once daily for a year. This study also investigated the effect of aerobic exercise in a 2 x 2 factorial design. For the purposes of this review, we combined data for all participants receiving vitamin B supplementation or placebo (i.e. with or without aerobic exercise) into single experimental and control groups. </p> </li> </ul> </p> </section> <section id="CD011905-sec-0078"> <h6 class="title">Outcomes</h6> <p>None of the studies reported on our primary outcome of incidence of all‐cause dementia (although diagnosis of dementia by DSM‐IV was listed as a secondary outcome in the protocol for <a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>). </p> <p>Four of the five studies measured overall cognitive function with the MMSE (<a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>, <a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a>, <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a>, <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>). </p> <p>We were able to extract data on episodic memory from three studies, which assessed delayed recall on the Hopkins Verbal Learning Test (<a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>), word learning (<a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a>) and the Auditory Verbal Learning Test (<a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>). We extracted data on executive function from four studies, which used CLOX (<a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>), the Stroop test (<a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a>; <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>) and the Frontal Assessment Battery (<a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a>). We extracted data on speed of processing from three studies, which used Trail‐making Test A (<a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a>), digit cancellation (<a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a>), and the Digit‐Symbol Substitution Test (<a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>). </p> <p>Only <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a> reported on quality of life, using the dementia‐specific D‐QOL scale. </p> <p><a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> reported overall clinical impression using global CDR scores. </p> <p><a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a> reported functional performance on a 14‐item Chinese ADL scale. </p> <p><a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> reported efficacy results separately for participants with high or low total homocysteine (tHCy) (based on the median values at baseline). However, it was possible to calculate results for the whole experimental intervention and control groups from the reported means and standard deviations. <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a> reported results for men and women separately in each group, but some of the outcomes were reported in enough detail to allow us to combine the data for men and women. </p> <p>Data on adverse events were reported by <a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> and <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>. </p> </section> </section> <section id="CD011905-sec-0079"> <h5 class="title">Comparison 2: Vitamin E versus placebo ‐ description of study</h5> <p>One study with 769 participants investigated this comparison (<a href="./references#CD011905-bbs2-0006" title="BlackerD . Neither vitamin E nor donepezil delays progression from amnestic mild cognitive impairment to Alzheimer's disease in the long term. Evidence‐Based Mental Health2006;9(1):20. FleisherAS , SowellBB , TaylorC , GamstAC , PetersenRC , ThalLJ , et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology2007;68(19):1588‐95. GrundmanM . Vitamin E and Alzheimer disease: the basis for additional clinical trials. The American Journal of Clinical Nutrition February 1, 2000;71(2):630S‐636S. PetersenR , GrundmanM , ThomasR , ThalL . Donepezil and vitamin E as treatments for mild cognitive impairment. Neurobiology of Aging2004;25(Supplement 2):S20. PetersenRC , ThomasRG , GrundmanM , BennettD , DoodyR , FerrisS , et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. The New England journal of medicine2005;352(23):2379‐88. ">Petersen 2005</a>). The study also had a donepezil arm. The primary outcome of the study was time to development of possible or probable Alzheimer's disease. </p> <section id="CD011905-sec-0080"> <h6 class="title">Setting</h6> <p>The study took place at 69 Alzheimer's Disease Cooperative Study (ADCS) sites in the US and Canada. </p> </section> <section id="CD011905-sec-0081"> <h6 class="title">Participants</h6> <p>Participants were aged 55 to 90 years and had amnestic MCI of a degenerative nature (insidious onset and gradual progression). Specific cognition‐related inclusion criteria were impaired memory, a logical memory delayed‐recall score approximately 1.5 to 2 SD below an education‐adjusted norm and a score of 24 to 30 on the MMSE, as well as a CDR global score of 0.5. </p> </section> <section id="CD011905-sec-0082"> <h6 class="title">Intervention</h6> <p>The experimental group of interest to this review received 2000 IU vitamin E (1000 IU twice daily), placebo donepezil, and a multivitamin (containing 15 IU of vitamin E) for three years. The comparator group received placebo vitamin E, placebo donepezil and the same multivitamin. Any participant who met clinical criteria for Alzheimer's disease at any time in the study was offered open‐label donepezil until study completion. </p> </section> <section id="CD011905-sec-0083"> <h6 class="title">Outcomes</h6> <p>The study assessed progression to possible or probable Alzheimer's disease. Overall cognitive function was assessed with the MMSE and with a composite score derived from a battery of individual neuropsychological tests. Composite scores of interest to this review were also derived for the domains of memory and executive function (and additional composites for language and visuospatial function). Clinical global impression was assessed using the Global Deterioration Scale (GDS) and the CDR. Functional performance was assessed using the ADCS Mild Cognitive Impairment ADL Scale. Data on individual adverse events were reported by treatment group if they occurred in at least 5% of subjects in the donepezil or vitamin E group and at least two times in the placebo group during the double‐blind phase. The number of deaths in each treatment group was also reported. </p> </section> </section> <section id="CD011905-sec-0084"> <h5 class="title">Comparison 3: Vitamin E + vitamin C versus placebo ‐ description of study</h5> <p>One study investigated this comparison (<a href="./references#CD011905-bbs2-0005" title="NaeiniAM , ElmadfaI , DjazayeriA , BarekatainM , AghayeghazviniMR , JalaliM , et al. Effect of vitamin E and C supplementation on elderly with mild cognitive impairment (MCI) in Isfahan, Iran. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):1145. NaeiniAM , ElmadfaI , DjazayeryA , BarekatainM , GhazviniMR , DjalaliM , et al. The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double‐blind, randomized, placebo‐controlled trial. European Journal of Nutrition2014;53(5):1255‐62. ">Naeini 2014</a>). It reported data on the 256 participants who completed the study (out of 296 who were randomised). </p> <section id="CD011905-sec-0085"> <h6 class="title">Setting</h6> <p>The study took place at a single centre in Iran with participants recruited from community clubs for retired people. </p> </section> <section id="CD011905-sec-0086"> <h6 class="title">Participants</h6> <p>Dementia was listed as an exclusion criterion, but there was no information on how this was applied. Participants were defined as having MCI and identified as eligible for inclusion on the basis of a score of 21 to 26 on the validated Iranian version of the MMSE. We considered this not to be an adequate definition of MCI. However, we decided to include the study, downgrading the result for indirectness in relation to our review question. </p> </section> <section id="CD011905-sec-0087"> <h6 class="title">Intervention</h6> <p>The experimental intervention was 300 mg vitamin E (DL‐alpha‐tocopherol) + 400 mg vitamin C once daily for one year. The comparator was placebo. </p> </section> <section id="CD011905-sec-0088"> <h6 class="title">Outcome</h6> <p>The only outcome of interest to this review was overall cognitive functioning assessed with the MMSE. </p> </section> </section> <section id="CD011905-sec-0089"> <h5 class="title">Comparison 4: Chromium picolinate versus placebo ‐ description of study</h5> <p>One small study with 26 participants contributed data to this comparison (<a href="./references#CD011905-bbs2-0004" title="KrikorianR , EliassenJC , BoespflugEL , NashTA , ShidlerMD . Improved cognitive‐cerebral function in older adults with chromium supplementation. Nutritional Neuroscience2010;13(3):116‐22. ">Krikorian 2010</a>). </p> <section id="CD011905-sec-0090"> <h6 class="title">Setting</h6> <p>This single centre study recruited participants via community advertisement.</p> </section> <section id="CD011905-sec-0091"> <h6 class="title">Participants</h6> <p>Participants had a global rating of 0.5 on the CDR.</p> </section> <section id="CD011905-sec-0092"> <h6 class="title">Intervention</h6> <p>The experimental intervention was chromium picolinate containing 1000 mcg elemental chromium once daily for 12 weeks. The comparator was placebo. </p> </section> <section id="CD011905-sec-0093"> <h6 class="title">Outcome</h6> <p>The only outcome of interest to this review was episodic memory assessed with the California Verbal Learning Test (CVLT). </p> </section> </section> </section> <section id="CD011905-sec-0094"> <h4 class="title">Excluded studies</h4> <p>The <a href="./references#CD011905-sec-0172" title="">Characteristics of excluded studies</a> table shows the reasons for exclusion of 55 studies which were assessed in full text. The most common reasons for exclusion were the wrong population (participants did not have MCI) or the wrong intervention (included additional components or was given for less than 12 weeks). </p> <p>Three studies are awaiting classification. In all three cases, we have been unable to obtain additional information from the authors at the time of writing. No results were available from one study. Results from the other two trials have been published, but we considered that essential information on various details of the methods, sample sizes, or results was missing. </p> <p>We identified one ongoing trial of vitamin D supplementation which, according to the trial register, was due to be completed in July 2018. </p> </section> </section> <section id="CD011905-sec-0095"> <h3 class="title">Risk of bias in included studies</h3> <p>We describe the risk of bias of the included studies in the table, <a href="./references#CD011905-sec-0171" title="">Characteristics of included studies</a>. Our 'Risk of bias' judgments are also depicted in the 'Risk of bias' summary and 'Risk of bias' graph (<a href="#CD011905-fig-0002">Figure 2</a> and <a href="#CD011905-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD011905-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011905-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD011905-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011905-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD011905-sec-0096"> <h4 class="title">Allocation</h4> <p>Three studies (<a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>, <a href="./references#CD011905-bbs2-0006" title="BlackerD . Neither vitamin E nor donepezil delays progression from amnestic mild cognitive impairment to Alzheimer's disease in the long term. Evidence‐Based Mental Health2006;9(1):20. FleisherAS , SowellBB , TaylorC , GamstAC , PetersenRC , ThalLJ , et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology2007;68(19):1588‐95. GrundmanM . Vitamin E and Alzheimer disease: the basis for additional clinical trials. The American Journal of Clinical Nutrition February 1, 2000;71(2):630S‐636S. PetersenR , GrundmanM , ThomasR , ThalL . Donepezil and vitamin E as treatments for mild cognitive impairment. Neurobiology of Aging2004;25(Supplement 2):S20. PetersenRC , ThomasRG , GrundmanM , BennettD , DoodyR , FerrisS , et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. The New England journal of medicine2005;352(23):2379‐88. ">Petersen 2005</a>, <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a>) provided enough information to judge the risk of selection bias to be low. The remaining five studies provided insufficient information on randomisation methods so we judged them to be at unclear risk of selection bias. </p> </section> <section id="CD011905-sec-0097"> <h4 class="title">Blinding</h4> <p><a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a> was an open‐label study which we judged to have a high risk of performance bias and an unclear risk of detection bias. There was also a lack of information about blinding from <a href="./references#CD011905-bbs2-0004" title="KrikorianR , EliassenJC , BoespflugEL , NashTA , ShidlerMD . Improved cognitive‐cerebral function in older adults with chromium supplementation. Nutritional Neuroscience2010;13(3):116‐22. ">Krikorian 2010</a> and <a href="./references#CD011905-bbs2-0005" title="NaeiniAM , ElmadfaI , DjazayeriA , BarekatainM , AghayeghazviniMR , JalaliM , et al. Effect of vitamin E and C supplementation on elderly with mild cognitive impairment (MCI) in Isfahan, Iran. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):1145. NaeiniAM , ElmadfaI , DjazayeryA , BarekatainM , GhazviniMR , DjalaliM , et al. The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double‐blind, randomized, placebo‐controlled trial. European Journal of Nutrition2014;53(5):1255‐62. ">Naeini 2014</a>. The other studies were at low risk of bias in this domain. </p> </section> <section id="CD011905-sec-0098"> <h4 class="title">Incomplete outcome data</h4> <p>The longer studies ‐ <a href="./references#CD011905-bbs2-0006" title="BlackerD . Neither vitamin E nor donepezil delays progression from amnestic mild cognitive impairment to Alzheimer's disease in the long term. Evidence‐Based Mental Health2006;9(1):20. FleisherAS , SowellBB , TaylorC , GamstAC , PetersenRC , ThalLJ , et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology2007;68(19):1588‐95. GrundmanM . Vitamin E and Alzheimer disease: the basis for additional clinical trials. The American Journal of Clinical Nutrition February 1, 2000;71(2):630S‐636S. PetersenR , GrundmanM , ThomasR , ThalL . Donepezil and vitamin E as treatments for mild cognitive impairment. Neurobiology of Aging2004;25(Supplement 2):S20. PetersenRC , ThomasRG , GrundmanM , BennettD , DoodyR , FerrisS , et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. The New England journal of medicine2005;352(23):2379‐88. ">Petersen 2005</a> and <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> ‐ lost high numbers of participants to follow‐up and we considered them to be at high risk of attrition bias by the end of the study. We judged the risk of attrition bias in <a href="./references#CD011905-bbs2-0005" title="NaeiniAM , ElmadfaI , DjazayeriA , BarekatainM , AghayeghazviniMR , JalaliM , et al. Effect of vitamin E and C supplementation on elderly with mild cognitive impairment (MCI) in Isfahan, Iran. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):1145. NaeiniAM , ElmadfaI , DjazayeryA , BarekatainM , GhazviniMR , DjalaliM , et al. The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double‐blind, randomized, placebo‐controlled trial. European Journal of Nutrition2014;53(5):1255‐62. ">Naeini 2014</a> to be unclear due to a lack of information on the group allocation of those who dropped out. The risk was also unclear in <a href="./references#CD011905-bbs2-0004" title="KrikorianR , EliassenJC , BoespflugEL , NashTA , ShidlerMD . Improved cognitive‐cerebral function in older adults with chromium supplementation. Nutritional Neuroscience2010;13(3):116‐22. ">Krikorian 2010</a>, where there was no information about whether or not there were any missing data. The remaining studies were at low risk of bias in this domain. </p> </section> <section id="CD011905-sec-0099"> <h4 class="title">Selective reporting</h4> <p>We judged there to be a high risk of reporting bias in two studies. <a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> mentioned a number of outcomes in the protocol, including some relevant to this review, which were not reported. <a href="./references#CD011905-bbs2-0006" title="BlackerD . Neither vitamin E nor donepezil delays progression from amnestic mild cognitive impairment to Alzheimer's disease in the long term. Evidence‐Based Mental Health2006;9(1):20. FleisherAS , SowellBB , TaylorC , GamstAC , PetersenRC , ThalLJ , et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology2007;68(19):1588‐95. GrundmanM . Vitamin E and Alzheimer disease: the basis for additional clinical trials. The American Journal of Clinical Nutrition February 1, 2000;71(2):630S‐636S. PetersenR , GrundmanM , ThomasR , ThalL . Donepezil and vitamin E as treatments for mild cognitive impairment. Neurobiology of Aging2004;25(Supplement 2):S20. PetersenRC , ThomasRG , GrundmanM , BennettD , DoodyR , FerrisS , et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. The New England journal of medicine2005;352(23):2379‐88. ">Petersen 2005</a> reported composite z‐scores rather than individual test results and did not report the number of participants in each analysis. <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> may have selected only some cognitive results from a larger neuropsychological test battery; we judged its risk of reporting bias to be unclear. We judged the risk in the other studies to be low, although for some studies there was no protocol and this judgement was based on the outcomes mentioned in the Methods sections of the papers being fully reported. </p> </section> <section id="CD011905-sec-0100"> <h4 class="title">Other potential sources of bias</h4> <p>We found no other obvious sources of bias and rated this risk as low for all studies.</p> </section> </section> <section id="CD011905-sec-0101"> <h3 class="title" id="CD011905-sec-0101">Effects of interventions</h3> <p>See: <a href="./full#CD011905-tbl-0001"><b>Summary of findings for the main comparison</b> B vitamins compared to placebo for MCI</a>; <a href="./full#CD011905-tbl-0002"><b>Summary of findings 2</b> Vitamin E compared to placebo for MCI</a>; <a href="./full#CD011905-tbl-0003"><b>Summary of findings 3</b> Vitamin E + vitamin C compared to placebo for MCI</a> </p> <section id="CD011905-sec-0102"> <h4 class="title">Comparison 1: B vitamins (folic acid, B12, B6) versus placebo</h4> <p>Five studies contributed data to this comparison (<a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>; <a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a>; <a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a>; <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a>; <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>). </p> <p><a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> differed significantly from the other studies in recruiting only participants who had a recent history of lacunar stroke and in following them up for up to five years. In our primary analyses, in order to maximise comparability with the other studies, we included data from the one‐year outcome point from <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a>, but we considered the population as a potential source of heterogeneity. We also reported the results of this study at later time points, although these were all associated with substantial loss of participants from follow‐up. </p> <p><a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> reported the data for participants with higher (above median) baseline total homocysteine (tHcy) and lower baseline total homocysteine levels separately. For the primary analyses, we combined these groups. However, we also reported and commented on their subgroup data. </p> <p><a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a> reported results separately for men and women; we have combined these data where we incorporated them in meta‐analyses. </p> <section id="CD011905-sec-0103"> <h5 class="title">Primary outcomes</h5> <section id="CD011905-sec-0104"> <h6 class="title">Incidence of all‐cause dementia</h6> <p>No study reported the incidence of all‐cause dementia.</p> </section> <section id="CD011905-sec-0105"> <h6 class="title">Overall cognitive functioning</h6> <p>Four studies used the MMSE to assess overall cognitive functioning (<a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>; <a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a>; <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a>; <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>). It is unknown what would constitute an important difference in MMSE score in this population. It is unlikely that MMSE is sensitive to small changes in cognition in people with MCI. We pooled data from three studies which reported MMSE in the form of mean score with standard deviation in each treatment group. </p> <p><a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a> presented MMSE results as medians with interquartile ranges (IQR) for men and women separately. After 12 months of treatment, the median (IQR) MMSE score among men was 28 (27 to 30) in the vitamin group and 29 (28 to 29) in the placebo group. For women, the median (IQR) MMSE score was identical in both vitamin and placebo groups: 29 (27 to 30). </p> <p>The pooled analysis of MMSE scores from the other three studies after six to 24 months was inconclusive due to imprecision; although the result slightly favoured B vitamins, we could not exclude the possibility of there being little or no effect (MD 0.44, 95%CI ‐0.23 to 1.12, 3 studies, 488 participants; <a href="./references#CD011905-fig-0008" title="">Analysis 1.1</a>, <a href="#CD011905-fig-0004">Figure 4</a>). There was high heterogeneity in this analysis (I<sup>2</sup> = 87%). This appeared to be due to a beneficial effect of B vitamins on MMSE score in <a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a>, which was the only open‐label (unblinded) study. We considered the evidence behind this result to be very low‐quality because of the imprecision, study limitations, and inconsistency. </p> <div class="figure" id="CD011905-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.1 Overall cognitive function (MMSE)." data-id="CD011905-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.1 Overall cognitive function (MMSE). </p> </div> </div> </div> <p><a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> reported the data separately for participants with higher and lower baseline total homocysteine (tHcy). The results in these subgroups were also imprecise: higher baseline tHcy (MD 0.70, 95% CI ‐0.16 to 1.56; participants = 111); lower baseline tHcy (MD ‐0.30, 95% CI ‐1.10 to 0.50; participants = 112). </p> <p><a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> did not find any significant effect of B vitamins on MMSE at any later time point (up to five years). </p> </section> </section> <section id="CD011905-sec-0106"> <h5 class="title">Secondary outcomes</h5> <section id="CD011905-sec-0107"> <h6 class="title">Specific cognitive functioning subdomain: episodic memory</h6> <p>We pooled data on episodic memory from three studies (<a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>; <a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a>; <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>). All used tests which involved delayed recall of word lists. There was probably little or no effect of six to 24 months of B vitamin supplementation on episodic memory (SMD 0.09, 95% CI ‐0.10 to 0.29; 3 studies, 397 participants; <a href="./references#CD011905-fig-0009" title="">Analysis 1.2</a>; <a href="#CD011905-fig-0005">Figure 5</a>). Heterogeneity was low (I<sup>2</sup> = 0%). We considered this to be moderate‐quality evidence, downgraded due to imprecision. </p> <div class="figure" id="CD011905-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.2 Episodic memory." data-id="CD011905-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.2 Episodic memory.</p> </div> </div> </div> <p>In <a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>, there was better episodic memory after 24 months in the group treated with vitamin B than in the group treated with placebo among participants with higher baseline tHCy (MD 1.30, 95% CI 0.02 to 2.58; participants = 111), but episodic memory did not differ significantly between intervention groups among participants with lower baseline tHcy (MD ‐0.30, 95% CI ‐1.58 to 0.98; participants = 112). The authors had analysed this outcome by logistic regression at five time points, starting from the 3rd month of the study, and estimated that after two years of the vitamin B intervention, participants taking vitamin B had a 69% higher likelihood of correct word‐recall than those taking placebo (OR 1.69, P = 0.001) (<a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>). </p> </section> <section id="CD011905-sec-0108"> <h6 class="title">Specific cognitive functioning subdomain: executive functioning</h6> <p>Four studies assessed executive functioning using three different measures (<a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>; <a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a>; <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a>; <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>). We used CLOX‐1 data from the CLOX test and 'task 3' from the Stroop Colour‐Word Test. <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> reported only change‐from‐baseline data, so we were unable to pool these with data from the other studies. There was probably little or no effect of six to 24 months of B vitamin supplementation on executive functioning (SMD 0.03, 95% CI ‐0.23 to 0.29; 3 studies, 392 participants; <a href="./references#CD011905-fig-0010" title="">Analysis 1.3</a>; <a href="#CD011905-fig-0006">Figure 6</a>). Heterogeneity was modest (I<sup>2</sup> = 30%). We considered this to be moderate‐quality evidence, downgraded due to imprecision. <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> reported no significant difference between B vitamin and placebo groups on change from baseline in the Frontal Assessment Battery at any time point from one to five years. </p> <div class="figure" id="CD011905-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.3 Executive function." data-id="CD011905-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.3 Executive function.</p> </div> </div> </div> <p>From <a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a>, there was no evidence of a difference in CLOX‐1 score between intervention groups among participants with either higher baseline tHcy (MD 0.30, 95% CI ‐0.50 to 1.10; participants = 111) or lower baseline tHCy (MD 0.50, 95% CI ‐0.13 to 1.13, participants = 112). </p> <p><a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> did not find any significant effect of B vitamins on executive functioning at any later time point (up to five years). </p> </section> <section id="CD011905-sec-0109"> <h6 class="title">Specific cognitive functioning subdomain: speed of processing</h6> <p>Three studies assessed speed of processing using three different measures (<a href="./references#CD011905-bbs2-0002" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98(5):960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84(2):361‐70. [PUBMED: 16895884] NCT00111267 . Oral vitamin B12 supplementation and cognitive performance in elderly people. clinicaltrials.gov/ct2/show/NCT00111267 (first received 18 May 2005). ">Eussen 2006</a>; <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a>; <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>). Again, we were unable to include data from <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> in the meta‐analysis because only change‐from‐baseline data were available. There was probably little or no effect of six to 24 months of B vitamin supplementation on speed of processing (SMD 0.04, 95% CI ‐0.26 to 0.34; 2 studies, 173 participants; <a href="./references#CD011905-fig-0011" title="">Analysis 1.4</a>; <a href="#CD011905-fig-0007">Figure 7</a>). Heterogeneity was low (I<sup>2</sup> = 0%). We considered this to be moderate‐quality evidence, downgraded due to imprecision. <a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> reported no significant difference in change‐from‐baseline of speed of processing (digit cancellation) between B vitamin and placebo groups at any time point from one to five years. </p> <div class="figure" id="CD011905-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.4 Speed of processing." data-id="CD011905-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.4 Speed of processing.</p> </div> </div> </div> <p><a href="./references#CD011905-bbs2-0007" title="NCT00097669 . VITATOPS: a study of vitamins to prevent stroke. clinicaltrials.gov/ct2/show/NCT00097669 (first received 24 November 2004). TingS , EarnestA , LiH , ShahulH , ChenC , TanE‐K . B vitamins and cognition in subjects with small vessel disease: a substudy of VITATOPS, a randomized, placebo‐controlled trial. Journal of the Neurological Sciences2017;379:124‐6. VITATOPS Trial Study Group. The VITATOPS (vitamins to prevent stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13(2):120‐6. ">Ting 2017</a> did not find any significant effect of B vitamins on speed of processing at any later time point (up to five years). </p> </section> <section id="CD011905-sec-0110"> <h6 class="title">Quality of life, either generic or disease‐specific</h6> <p>One study (<a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a>) reported dementia‐specific quality of life using D‐QOL.There was no evidence of any effect of B vitamins after one year (MD 0, 95% CI ‐0.1 to 0.1; 1 study, 138 participants; <a href="./references#CD011905-fig-0012" title="">Analysis 1.5</a>). We considered this to be moderate‐quality evidence, downgraded due to imprecision. </p> </section> <section id="CD011905-sec-0111"> <h6 class="title">Clinical global impression</h6> <p><a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> assessed overall clinical state using CDR. The authors reported that "(i)n the whole intention‐to‐treat cohort, there was no significant effect of B vitamins on CDR (P = 0.23)", nor was there a significant interaction with baseline tHcy split by median. However, when they stratified tHcy by quartiles, they noted a significant benefit of B vitamins on CDR in the quartile with the highest tHcy at baseline (P = 0.039, Fisher's exact test). In this subgroup, they calculated that "the odds of having CDR=0 at follow‐up is five times greater in the active‐treatment group compared with placebo (P = 0.02)." It was not clear whether or not this was a prespecified analysis. </p> </section> <section id="CD011905-sec-0112"> <h6 class="title">Functional performance</h6> <p>One study (<a href="./references#CD011905-bbs2-0003" title="FanJ , HeB , SunF . Influence of folic acid intervention on cognitive function of community patients with mild cognitive impairment. Chinese Nursing Research2017;31(32):4161‐3. ">Fan 2017</a>) assessed functional performance using a 14‐item ADL scale (range of possible scores 14 to 56, with a lower score representing a better outcome). There may be a small beneficial effect of B vitamins on functional performance after six months (MD ‐0.78, 95% CI ‐1.35 to ‐0.21; 1 study, 75 participants; <a href="./references#CD011905-fig-0013" title="">Analysis 1.6</a>). We considered this to be very low‐quality evidence, downgraded due to imprecision and very serious concern about study limitations. </p> </section> <section id="CD011905-sec-0113"> <h6 class="title">Number of participants experiencing one or more serious adverse events (SAE)</h6> <p>Two papers reported adverse events. <a href="./references#CD011905-bbs2-0008" title="vanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16(7):1137‐46. vanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. vanUffelenJG , Hopman‐RockM , ChinapawMJ , VanMechelenW . Protocol for project FACT: a randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]. BMC Geriatrics2005;5:18. ">van Uffelen 2008</a> reported minor adverse events in 3/179 randomised participants (2 in B vitamins group, 1 in placebo group). <a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> reported 242 adverse events in total in the B vitamins group (n = 133) and 271 in the placebo group (n = 133) over two years. </p> </section> <section id="CD011905-sec-0114"> <h6 class="title">Mortality</h6> <p><a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> reported two deaths in the B vitamins group (2/133) but none in the placebo group (0/133). No deaths were reported by the other studies. </p> </section> <section id="CD011905-sec-0115"> <h6 class="title">Biomarkers</h6> <p><a href="./references#CD011905-bbs2-0001" title="DouaudG , RefsumH , deJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America2013;110(23):9523‐8. SmithAD . Disease‐modification in mild cognitive impairment by lowering homocysteine. Neurobiology of Aging2012;33(Suppl 1):S32. SmithAD , SmithSM , deJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5(9):e12244. deJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27(6):592‐600. ">de Jager 2012</a> reported the rate of brain atrophy measured by MRI. Out of 133 participants who started treatment in each group, 85 in the vitamin and 83 in the placebo group had serial MRI scans which were technically suitable for analysis. After adjustment for age, the rate of brain atrophy per year was reported to be 29.6% lower in the active treatment group (0.76%, 95% CI 0.63 to 0.90) than in the placebo group (1.08%, 95% CI 0.94 to 1.22) (P = 0.001). </p> </section> </section> </section> <section id="CD011905-sec-0116"> <h4 class="title">Comparison 2: Vitamin E versus placebo</h4> <p>One study with 516 participants contributed data for this comparison (<a href="./references#CD011905-bbs2-0006" title="BlackerD . Neither vitamin E nor donepezil delays progression from amnestic mild cognitive impairment to Alzheimer's disease in the long term. Evidence‐Based Mental Health2006;9(1):20. FleisherAS , SowellBB , TaylorC , GamstAC , PetersenRC , ThalLJ , et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology2007;68(19):1588‐95. GrundmanM . Vitamin E and Alzheimer disease: the basis for additional clinical trials. The American Journal of Clinical Nutrition February 1, 2000;71(2):630S‐636S. PetersenR , GrundmanM , ThomasR , ThalL . Donepezil and vitamin E as treatments for mild cognitive impairment. Neurobiology of Aging2004;25(Supplement 2):S20. PetersenRC , ThomasRG , GrundmanM , BennettD , DoodyR , FerrisS , et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. The New England journal of medicine2005;352(23):2379‐88. ">Petersen 2005</a>). </p> <p>Sample sizes for change scores were not reported for some outcomes, making it impossible to re‐analyse the data without imputation of sample sizes. It was difficult to tell how the study had treated the missing data arising from participants who discontinued the study during the double‐blind phase (reported as 72 in the vitamin E group and 66 from the placebo group), and participants who had developed Alzheimer’s Disease by 36 months and had therefore been transferred to an open‐label phase for treatment with donepezil (76 participants in the vitamin E group and 73 in the placebo group). </p> <p>A z‐score was calculated for cognitive domain scores. Positive numbers on this score indicated better outcomes. </p> <section id="CD011905-sec-0117"> <h5 class="title">Primary outcomes</h5> <section id="CD011905-sec-0118"> <h6 class="title">Incidence of all‐cause dementia</h6> <p>The study did not report the incidence of all‐cause dementia, but did report the incidence of Alzheimer's dementia. By 12 months, 33 participants in the vitamin E group and 38 in the placebo group had progressed to Alzheimer's dementia. By 36 months, these numbers were 76 and 73 respectively. There was no significant difference between vitamin E and placebo groups in the probability of progression from MCI to Alzheimer's dementia over 36 months based on Cox analysis (HR 1.02; 95% CI 0.74 to 1.41; n = 516; 1 study) (<a href="./references#CD011905-bbs2-0006" title="BlackerD . Neither vitamin E nor donepezil delays progression from amnestic mild cognitive impairment to Alzheimer's disease in the long term. Evidence‐Based Mental Health2006;9(1):20. FleisherAS , SowellBB , TaylorC , GamstAC , PetersenRC , ThalLJ , et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology2007;68(19):1588‐95. GrundmanM . Vitamin E and Alzheimer disease: the basis for additional clinical trials. The American Journal of Clinical Nutrition February 1, 2000;71(2):630S‐636S. PetersenR , GrundmanM , ThomasR , ThalL . Donepezil and vitamin E as treatments for mild cognitive impairment. Neurobiology of Aging2004;25(Supplement 2):S20. PetersenRC , ThomasRG , GrundmanM , BennettD , DoodyR , FerrisS , et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. The New England journal of medicine2005;352(23):2379‐88. ">Petersen 2005</a>). There was also no significant difference between groups at any of the six‐monthly time points between baseline and 36 months (prespecified analyses). We considered this to be moderate‐quality evidence, downgraded due to imprecision. </p> </section> <section id="CD011905-sec-0119"> <h6 class="title">Overall cognitive functioning</h6> <p>This was measured using MMSE and ADAS‐Cog at a six‐monthly interval from baseline for three years. At 36 months, the change from baseline in MMSE score (range 0 to 30, a higher score was better) was ‐2.20 ± 3.64 in the vitamin E group and ‐2.75 ± 4.04 in the placebo group. This was reported not to be statistically significant. We were not able to calculate the mean differences since sample sizes were not reported. There was also reported to be no significant difference in the change from baseline for ADAS Cog (modified) score (range 0 to 85, a higher was worse); this was 3.98 ± 7.56 in the vitamin E group and 3.72 ± 8.54 in the placebo group. We considered this to be low‐quality evidence, downgraded due to risk of bias and imprecision (single study, estimated sample size). </p> </section> </section> <section id="CD011905-sec-0120"> <h5 class="title">Secondary outcomes</h5> <p>We considered the evidence on all of the secondary outcomes reported here to be low‐quality, downgraded due to risk of bias and imprecision (single study, estimated sample size in each analysis). </p> <section id="CD011905-sec-0121"> <h6 class="title">Specific cognitive functioning subdomain: episodic memory</h6> <p>The study reported the change from baseline in a standardised z‐score for a memory domain, incorporating ADAS‐cog immediate and delayed word‐recall scores and the New York University immediate and delayed paragraph‐recall scores. Positive numbers indicated improvement. At 36 months, the change from baseline was ‐0.31 ± 0.59 in the vitamin E group and ‐0.28 ± 0.62 in the placebo group. This was reported not to be statistically significant. Sample size was not reported. </p> </section> <section id="CD011905-sec-0122"> <h6 class="title">Specific cognitive functioning subdomain: executive functioning</h6> <p>The study reported the change from baseline in a standardised z‐score for an executive function domain, incorporating the Digits‐Backward test, Symbol Digit Modalities test, and Number‐Cancellation test. Positive numbers indicated improvement. At 36 months, the change from baseline was ‐0.19 ± 0.48 in the vitamin E group and ‐0.19 ± 0.53 in the placebo group. This was reported not to be statistically significant. Sample size was not reported. </p> </section> <section id="CD011905-sec-0123"> <h6 class="title">Specific cognitive functioning subdomain: speed of processing</h6> <p>Not reported in the study.</p> </section> <section id="CD011905-sec-0124"> <h6 class="title">Quality of life, either generic or disease‐specific</h6> <p>Not reported in the study.</p> </section> <section id="CD011905-sec-0125"> <h6 class="title">Clinical global impression</h6> <p>The study reported the change in Global Deterioration Scale (range 0 to 7, higher was worse) from baseline to 36 months (0.64 ± 0.96 in the vitamin E group, 0.56 ± 0.99 in the placebo group). The number of participants in the analysis was not reported. This difference was described as not statistically significant in the study report. </p> </section> <section id="CD011905-sec-0126"> <h6 class="title">Functional performance</h6> <p>This was measured with the Activities of Daily Living Scale, which can range from 0 to 53, with higher scores indicating better function. The change from baseline at 36 months was ‐5.63 ± 8.75 in the vitamin E group and ‐6.39 ± 8.99 in the placebo group. The sample sizes used to calculate these values were not reported. The difference was described as not statistically significant. </p> </section> <section id="CD011905-sec-0127"> <h6 class="title">Number of participants experiencing one or more serious adverse events (SAE)</h6> <p>This was not reported in the study. There was no statistically significant difference between vitamin E and placebo groups in the rate of ten individual adverse events which were reported because they occurred in at least 5% of participants receiving donepezil or vitamin E and at least twice among participants receiving placebo. </p> </section> <section id="CD011905-sec-0128"> <h6 class="title">Mortality</h6> <p>Five subjects died in each of the vitamin E (n = 257) and placebo (n = 259) groups during the double‐blind phase. </p> </section> <section id="CD011905-sec-0129"> <h6 class="title">Other validated biomarkers</h6> <p>Not reported in the review.</p> </section> </section> </section> <section id="CD011905-sec-0130"> <h4 class="title">Comparison 3: Vitamin E and C versus placebo</h4> <p>Only one study <a href="./references#CD011905-bbs2-0005" title="NaeiniAM , ElmadfaI , DjazayeriA , BarekatainM , AghayeghazviniMR , JalaliM , et al. Effect of vitamin E and C supplementation on elderly with mild cognitive impairment (MCI) in Isfahan, Iran. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):1145. NaeiniAM , ElmadfaI , DjazayeryA , BarekatainM , GhazviniMR , DjalaliM , et al. The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double‐blind, randomized, placebo‐controlled trial. European Journal of Nutrition2014;53(5):1255‐62. ">Naeini 2014</a> contributed to this comparison. </p> <section id="CD011905-sec-0131"> <h5 class="title">Primary outcomes</h5> <section id="CD011905-sec-0132"> <h6 class="title">Incidence of all‐cause dementia</h6> <p>Not assessed.</p> </section> <section id="CD011905-sec-0133"> <h6 class="title">Overall cognitive functioning</h6> <p>This was measured using the Iranian version of the MMSE (validated for the local population, range 0 to 30) after one year of treatment. The mean and standard error of the mean at six and 12 months were reported. The difference between the groups was described as not statistically significant at either time point. </p> <p>We assumed that all participants described as completing the study were analysed and estimated the mean difference at the end of the study. This indicated that there may be no little or no effect of supplementation with vitamins E and C (MD 0.23, 95% CI ‐0.25 to 0.71; 1 study, 256 participants; <a href="./references#CD011905-fig-0014" title="">Analysis 3.1</a>).We considered this to be very low‐quality evidence, downgraded due to indirectness (inadequate definition of MCI), risk of bias, and imprecision (result from a single study). </p> </section> </section> <section id="CD011905-sec-0134"> <h5 class="title">Secondary outcomes</h5> <section id="CD011905-sec-0135"> <h6 class="title">Mortality</h6> <p>There was one reported death, but the treatment allocation of this person was not reported. </p> <p>None of our other secondary outcomes were reported.</p> </section> </section> </section> <section id="CD011905-sec-0136"> <h4 class="title">Comparison 4: Chromium picolinate versus placebo</h4> <p>Only one study <a href="./references#CD011905-bbs2-0004" title="KrikorianR , EliassenJC , BoespflugEL , NashTA , ShidlerMD . Improved cognitive‐cerebral function in older adults with chromium supplementation. Nutritional Neuroscience2010;13(3):116‐22. ">Krikorian 2010</a> contributed data to this comparison. This study was very small (n = 26). There were 15 participants in the intervention arm and 11 in the placebo arm. </p> <section id="CD011905-sec-0137"> <h5 class="title">Primary outcomes</h5> <section id="CD011905-sec-0138"> <h6 class="title">The incidence of all‐cause dementia</h6> <p>Not assessed.</p> </section> <section id="CD011905-sec-0139"> <h6 class="title">Overall cognitive functioning</h6> <p>Not assessed.</p> </section> </section> <section id="CD011905-sec-0140"> <h5 class="title">Secondary outcomes</h5> <section id="CD011905-sec-0141"> <h6 class="title">Specific cognitive functioning subdomain: episodic memory</h6> <p>This was measured using the Californian Verbal Learning test (test for episodic verbal learning and memory) at 12 weeks. Group differences were not significant for performances on the CVLT learning trials (46.8 versus 45.8; P = 0.72), short‐delay recall (9.4 versus 8.4; P = 0.30), long‐delay recall (9.3 versus 9.5; P = 0.78), or recognition memory (14.4 versus 14.2; P = 0.77). We considered this to be very low‐quality evidence due to serious concern about study limitations and very serious concern about imprecision. </p> <p>None of our other secondary outcomes were reported.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011905-sec-0142" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011905-sec-0142">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011905-sec-0215">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011905-sec-0142"></div> <section id="CD011905-sec-0143"> <h3 class="title" id="CD011905-sec-0143">Summary of main results</h3> <p>This review included eight RCTs which investigated the effect of vitamin or mineral supplements on the incidence of dementia or on cognitive function in participants with mild cognitive impairment at baseline. Five studies with 879 randomised participants investigated the effect of B vitamins; in four of these studies the intervention was a mixture of vitamins B12, B6 and folic acid and in one study it was folic acid only. The other supplements included were vitamin E (one study, 769 participants), vitamins E and C (one study, 256 participants) and chromium picolinate (one study, 26 participants). </p> <p>None of the included studies assessed the incidence of all‐cause dementia, one of our primary outcomes. One study found that there was probably no effect of vitamin E on the probability of progression from MCI to dementia due to Alzheimer's disease over three years. </p> <p>All of the studies reported on one or more measures of cognitive function.</p> <p>For B vitamins, we found very low‐quality evidence on overall cognitive function. There was probably little or no effect on any of our specific cognitive subdomains of interest (episodic memory, executive functioning, and speed of processing). Only one study reported on each of global clinical impression and quality of life, and there was no evidence of any effect. There was only very low‐quality evidence on functional performance from one small, open‐label study. The very few data available on adverse events or mortality did not suggest any difference between groups. The only study reporting biomarker data found a reduction in the rate of brain atrophy over two years in the B vitamin group. We added to our protocol the reporting of subgroup data by baseline homocysteine (tHcy) level. The one study that reported such data found that there may be a significant benefit of B vitamins on episodic memory ‐ but not overall cognitive function or executive function ‐ of participants with tHcy above the median at baseline. </p> <p>The study of vitamin E did not provide the data we needed to conduct analyses. The authors reported no significant effect of vitamin E supplementation on overall cognitive functioning, episodic memory, executive functioning, clinical global impression, functional performance, incidence of adverse events, or mortality. </p> <p>The quality of evidence on vitamins E and C in combination (effect on overall cognitive function) and on chromium picolinate (effect on episodic memory) was very low so we had very little confidence in the results. </p> </section> <section id="CD011905-sec-0144"> <h3 class="title" id="CD011905-sec-0144">Overall completeness and applicability of evidence</h3> <p>The five trials all included community‐dwelling participants aged over 55 with mild cognitive impairment. In one of the studies of B vitamins, participants all had mild B12 deficiency at baseline at a level which is common in older people, but otherwise participants were not selected on the basis of nutritional status. Not all studies assessed nutritional status at baseline, but participants in all other studies had, or could be expected to have had, normal dietary intake for their population of origin and a low risk of specific vitamin or mineral deficiencies. The results of this review do not apply to people with significant nutritional deficiencies. In one study, participants had vascular cognitive impairment after a recent lacunar stroke; in the other studies, there was no selection for cause of cognitive impairment. Overall, the participants seemed to be quite well representative of people with MCI seen in clinical practice. The range of vitamin and mineral supplements tested was limited. Only B vitamins were investigated in more than one study and these studies all used different dose combinations so that it was not possible to isolate effects of individual B vitamins or to assess dose‐response relationships. The dose of folic acid used in some studies was similar to the maximum dietary intake in the UK population; doses of other vitamins were at least ten times more than the reference nutrient intake (see <a href="./appendices#CD011905-sec-0156">Appendix 3</a>). All trials assessed different primary and secondary outcomes. Only one trial assessed progression to dementia due to Alzheimer's disease and none assessed progression to all‐cause dementia. Overall cognitive function was assessed mainly with the MMSE which has limited sensitivity to detect small changes in cognition in a population with MCI. There were few data on quality of life, global impression, functional performance, or adverse events. Only one study reported a biomarker outcome which has been widely used in MCI populations, namely, the rate of atrophy on structural MRI. </p> </section> <section id="CD011905-sec-0145"> <h3 class="title" id="CD011905-sec-0145">Quality of the evidence</h3> <p>There was some moderate‐quality evidence relating to the effect of B vitamins on specific cognitive domains and quality of life, and the effect of vitamin E on incidence of Alzheimer's dementia. The remaining evidence was of low‐ or very low‐quality. Some of the more serious concerns about risk of bias related to performance bias in one open‐label study, attrition bias in two studies and selective outcome reporting in two studies. For the comparisons of the vitamin E and C combination and chromium picolinate with placebo, the only evidence was of very low‐quality because of study limitations and very small sample sizes. The evidence concerning a possible differential effect on episodic memory in participants with higher or lower baseline homocysteine levels came from subgroups in a single study and must be regarded as preliminary. </p> </section> <section id="CD011905-sec-0146"> <h3 class="title" id="CD011905-sec-0146">Potential biases in the review process</h3> <p>We considered search biases to be unlikely. We used a standardised search strategy to identify articles, including unpublished studies. These search methods included a single‐concept search across multiple sources along with a search of the Cochrane trial register. This sensitive search approach may have identified studies that would have potentially been overlooked using less rigorous search methods. However, we found too few studies to conduct any formal tests to assess the likelihood of publication bias and this remains possible. </p> <p>We selected only three specific cognitive subdomains as secondary outcomes. It is possible that effects on other specific cognitive subdomains could have been missed. </p> <p>Where cognition is measured using several different instruments, it can be difficult to categorise instruments into specific cognitive subdomains and to make data pooling decisions. We tried to avoid bias by using a prespecified, hierarchical list of the most commonly used instruments, but it is possible that different categorisations could have led to different results. </p> </section> <section id="CD011905-sec-0147"> <h3 class="title" id="CD011905-sec-0147">Agreements and disagreements with other studies or reviews</h3> <p>We are not aware of other reviews of similar scope. The Collaboration of B‐vitamin Treatment Trialists have conducted a meta‐analysis of data on more than 22,000 older participants who were not selected for specific cognitive diagnoses (<a href="./references#CD011905-bbs2-0083" title="ClarkeR , BennettD , ParishS , LewingtonS , SkeaffM , et al. Effects of homocysteine lowering with B vitamins on cognitive aging: meta‐analysis of 11 trials with cognitive data on 22,000 individuals. American Journal of Clinical Nutrition2014;100(2):657‐66. ">Clarke 2014</a>). This review found no effect of B vitamins on overall or domain‐specific cognitive function despite lowering serum homocysteine levels by &gt; 25%. Although not directly relevant to a population with mild cognitive impairment, this result does not support the hypotheses that B vitamin supplementation or homocysteine‐lowering are effective means to prevent cognitive decline. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011905-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011905-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011905-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011905-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.1 Overall cognitive function (MMSE)." data-id="CD011905-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.1 Overall cognitive function (MMSE). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.2 Episodic memory." data-id="CD011905-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.2 Episodic memory.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.3 Executive function." data-id="CD011905-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.3 Executive function.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.4 Speed of processing." data-id="CD011905-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 B vitamins versus placebo, outcome: 1.4 Speed of processing.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus placebo, Outcome 1 Overall cognitive function (MMSE)." data-id="CD011905-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus placebo, Outcome 1 Overall cognitive function (MMSE).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#CD011905-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus placebo, Outcome 2 Episodic memory." data-id="CD011905-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus placebo, Outcome 2 Episodic memory.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#CD011905-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus placebo, Outcome 3 Executive function." data-id="CD011905-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus placebo, Outcome 3 Executive function.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#CD011905-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus placebo, Outcome 4 Speed of processing." data-id="CD011905-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus placebo, Outcome 4 Speed of processing.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#CD011905-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus placebo, Outcome 5 Quality of life (D‐QOL)." data-id="CD011905-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus placebo, Outcome 5 Quality of life (D‐QOL).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#CD011905-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus placebo, Outcome 6 Functional performance (ADL)." data-id="CD011905-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus placebo, Outcome 6 Functional performance (ADL).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#CD011905-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011905-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/urn:x-wiley:14651858:media:CD011905:CD011905-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_t/tCD011905-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamins E and C versus placebo, Outcome 1 Overall cognitive function (MMSE)." data-id="CD011905-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Vitamins E and C versus placebo, Outcome 1 Overall cognitive function (MMSE). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#CD011905-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/media/CDSR/CD011905/image_n/nCD011905-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011905-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">B vitamins compared to placebo for MCI</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>B vitamins compared to placebo for MCI</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> MCI<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> B vitamins (B6, B12, folic acid)<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with B vitamins</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of dementia ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive function<br/> assessed with: MMSE<br/> Scale from: 0 to 30<br/> follow‐up: range 6 months to 24 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>MD with B vitamins was 0.44 MMSE points higher<br/> (0.23 lower to 1.12 higher) than with placebo * </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>488<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Due to the very low‐quality of the evidence, we cannot be sure of any effect of B vitamins on overall cognitive function. </p> <p>* 2 studies reported final score; 1 study reported change from baseline. From the 2 studies (n=150) which reported final scores, the mean MMSE with placebo was 26.97 points. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Episodic memory<br/> assessed with: various word list recall instruments<sup>a</sup><br/> follow‐up: range 6 months to 24 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>SMD with B vitamins was 0.09 higher<br/> (0.1 lower to 0.29 higher) than with placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>397<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>B vitamins probably resulted in little to no difference in episodic memory.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Executive function<br/> assessed with: various instruments<sup>b</sup><br/> follow‐up: range 6 months to 24 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>SMD with B vitamins was 0.03 higher<br/> (0.23 lower to 0.29 higher) than with placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>392<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>B vitamins probably resulted in little to no difference in executive function.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Speed of processing<br/> assessed with: various instruments<sup>c</sup><br/> follow‐up: range 6 months to 24 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>SMD with B vitamins was 0.04 higher<br/> (0.26 lower to 0.34 higher) than with placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>173<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>B vitamins probably resulted in little to no difference in speed of processing.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life<br/> assessed with: D‐QOL<br/> Scale from: 1 to 5<br/> follow‐up: 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life was 3.5 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0 points<br/> (0.1 lower to 0.1 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>138<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>B vitamins probably resulted in little to no difference in quality of life.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Reported by only one study (2/133 died in vitamin B group, 0/133 died in placebo group).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>MD:</b> Mean difference; <b>SMD:</b> Standardised mean difference; <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded due to risk of bias. One study was at high risk of performance bias and at unclear risk of selection and detection bias. </p> <p><sup>2</sup> Downgraded due to inconsistency. I<sup>2</sup> = 87%. </p> <p><sup>3</sup> Downgraded due to imprecision. 95% CI included little or no effect and small benefit of B vitamins. </p> <p><sup>4</sup> Downgraded due to imprecision. 95% CI included small effects in either direction. </p> <p><sup>5</sup> Downgraded due to imprecision. Result derived from one small study. </p> <p><sup>a</sup>Episodic memory assessed with Hopkins Verbal Learning Test, word learning and the Auditory Verbal Learning Test. </p> <p><sup>b</sup>Executive function assessed with CLOX, the Stroop test, and the Frontal Assessment Battery. </p> <p><sup>c</sup>Speed of processing assessed with Trail‐making Test A, digit cancellation, and the Digit‐Symbol Substitution Test. </p> <p><sup>CLOX: Clock drawing executive test<br/> D‐QOL: Dementia quality of life questionnaire</sup><br/> <sup>MCI: Mild cognitive impairment<br/> MMSE: Mini‐mental state examination</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">B vitamins compared to placebo for MCI</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011905-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vitamin E compared to placebo for MCI</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Vitamin E compared to placebo for MCI</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> MCI<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> vitamin E<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of dementia due to Alzheimer's disease<br/> follow‐up: 36 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>76 cases in vitamin E group and 73 cases in placebo group (HR 1.02, 95% CI 0.74 to 1.41) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>516<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning<br/> assessed with: MMSE and ADAS‐cog<br/> follow‐up: 36 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Single study reported no significant difference between groups in changes from baseline of MMSE or ADAS‐cog. Sample sizes not reported. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Episodic memory<br/> assessed with: z‐score incorporating various instruments<sup>a</sup><br/> follow‐up: 36 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Single study reported no significant difference between groups. Sample size not reported.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Executive functioning<br/> assessed with: z‐score incorporating various instruments<sup>b</sup><br/> follow‐up: 36 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Single study reported no significant difference between groups. Sample size not reported.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No significant difference in deaths reported between vitamin E, donepezil, and placebo groups during double‐blind phase of trial. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded due to imprecision. 95% CI around hazard ratio included possible effect in both directions. </p> <p><sup>2</sup> Downgraded due to imprecision. Single study. Sample size for this outcome not reported. </p> <p><sup>3</sup> Downgraded due to risk of bias. High risk of bias due to incomplete outcome data and selective reporting. </p> <p><sup>a</sup>Episodic memory assessed using standardised composite z‐score incorporating ADAS immediate and delayed word‐recall scores and the New York University immediate and delayed paragraph‐recall scores. </p> <p><sup>b</sup>Executive function assessed using standardised composite z‐score incorporating the digits‐backward test, Symbol Digit Modalities Test, and number‐cancellation test. </p> <p><sup>ADAS‐cog: Alzheimer's Disease Assessment Scale ‐ cognitive <br/> MCI: Mild cognitive impairment<br/> MMSE: Mini‐mental state examination</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vitamin E compared to placebo for MCI</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011905-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Vitamin E + vitamin C compared to placebo for MCI</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Vitamin E + vitamin C compared to placebo for MCI</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> MCI<br/> <b>Setting: c</b> ommunity<br/> <b>Intervention:</b> vitamin E + vitamin C<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vitamin E + vitamin C</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of dementia ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive function<br/> assessed with: MMSE (Iranian version)<br/> Scale from: 0 to 30<br/> follow‐up: 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall cognitive function was 26.6 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.23 points higher<br/> (0.25 lower to 0.71 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Due to very low‐quality evidence, we cannot be sure of any effect of vitamin C + vitamin E on overall cognitive function. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Episodic memory ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Executive function ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Speed of processing ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded due to risk of bias. Unclear risks of selection, performance, and attrition bias. </p> <p><sup>2</sup> Downgraded due to indirectness. Inadequate definition of MCI. </p> <p><sup>3</sup> Downgraded due to imprecision. Result from a single small study. </p> <p><sup>MCI: Mild cognitive impairment<br/> MMSE: Mini‐mental state examination</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Vitamin E + vitamin C compared to placebo for MCI</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/full#CD011905-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011905-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">B vitamins versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall cognitive function (MMSE) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>488</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [‐0.23, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Episodic memory <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.10, 0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Executive function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.23, 0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Speed of processing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.26, 0.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Quality of life (D‐QOL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.10, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Functional performance (ADL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.78 [‐1.35, ‐0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">B vitamins versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#CD011905-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011905-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Vitamins E and C versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall cognitive function (MMSE) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [‐0.25, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Vitamins E and C versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011905.pub2/references#CD011905-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011905.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011905-note-0015">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011905-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011905-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011905-note-0006">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD011905-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD011905-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011905-note-0003">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011905\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011905\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011905\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011905\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011905\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011905.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011905.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011905.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011905.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011905.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714078009"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011905.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714078013"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011905.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d65e07dcc937d',t:'MTc0MDcxNDA3OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 